0001019687-12-003861.txt : 20121102 0001019687-12-003861.hdr.sgml : 20121102 20121102164601 ACCESSION NUMBER: 0001019687-12-003861 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 10 CONFORMED PERIOD OF REPORT: 20120930 FILED AS OF DATE: 20121102 DATE AS OF CHANGE: 20121102 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Applied Nanotech Holdings, Inc CENTRAL INDEX KEY: 0000891417 STANDARD INDUSTRIAL CLASSIFICATION: COMMUNICATIONS EQUIPMENT, NEC [3669] IRS NUMBER: 760273345 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-11602 FILM NUMBER: 121177369 BUSINESS ADDRESS: STREET 1: 3006 LONGHORN BOULEVARD STREET 2: SUITE 107 CITY: AUSTIN STATE: TX ZIP: 78758 BUSINESS PHONE: 5123315020 MAIL ADDRESS: STREET 1: 3006 LONGHORN BOULEVARD STREET 2: SUITE 107 CITY: AUSTIN STATE: TX ZIP: 78758 FORMER COMPANY: FORMER CONFORMED NAME: NANO PROPRIETARY INC DATE OF NAME CHANGE: 20071105 FORMER COMPANY: FORMER CONFORMED NAME: NANO PROPRIETARY INC DATE OF NAME CHANGE: 20030702 FORMER COMPANY: FORMER CONFORMED NAME: SI DIAMOND TECHNOLOGY INC DATE OF NAME CHANGE: 19940318 10-Q 1 apnt_10q-093012.htm FORM 10-Q

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 10-Q

 

ý Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the quarterly period ended September 30, 2012

 

£ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

COMMISSION FILE NO. 1-11602

 

APPLIED NANOTECH HOLDINGS, INC.
(Exact name of registrant as specified in its charter)

 

TEXAS 76-0273345
(State or other jurisdiction of (I.R.S. Employer Identification No.)
incorporation or organization)  
   

 

3006 Longhorn Blvd., Suite 107  
Austin, Texas 78758
(Address of principal executive offices) (Zip Code)

 

(512) 339-5020

 

(Registrant's telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

  S Yes   £  No

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files.

  S Yes   £  No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definition of “accelerated filer”, “large accelerated filer”, and “smaller reporting company” in rule 12b-2 of the Act.

 

Large Accelerated Filer  o    Accelerated Filer  o  

Non-accelerated Filer  o Smaller Reporting Company  þ

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

  £ Yes   S  No

 

As of October 31, 2012, the registrant had 119,675,372 shares of common stock, par value $.001 per share, issued and outstanding.

 

 
 

APPLIED NANOTECH HOLDINGS, INC.

INDEX

 

Part I.  Financial Information Page
       
  Item 1. Financial Statements  
       
    Consolidated Balance Sheets--September 30, 2012 and December 31, 2011 3
       
    Consolidated Statements of Operations --Three Months and Nine Months Ended September 30, 2012 and 2011 4
       
    Consolidated Statements of Cash Flows --Nine Months Ended September 30, 2012 and 2011 5
       
    Notes  to Consolidated Financial Statements 6
       
  Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 8
       
  Item 3. Quantitative and Qualitative Disclosures about Market Risk 11
       
  Item 4. Controls and Procedures 11
       
Part II.  Other Information  
       
  Item 6. Exhibits 12
       
Signatures 13
         

 

2
 

PART I.  FINANCIAL INFORMATION

 

ITEM 1.  FINANCIAL STATEMENTS

 

APPLIED NANOTECH HOLDINGS, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

 

ASSETS  (Unaudited)
September 30,
2012		   December 31,
2011		 
Current assets:          
Cash and cash equivalents  $360,415   $3,071,783 
Accounts receivable – net of allowance for doubtful accounts   435,948    839,863 
Prepaid expenses and other current assets   698,881    153,021 
           
Total current assets   1,495,244    4,064,667 
           
Property and equipment, net   298,983    303,055 
Other assets   28,591    28,745 
Total assets  $1,822,818   $4,396,467 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)          
           
Current liabilities:          
Accounts payable  $725,764   $324,333 
Convertible notes payable   720,000    1,486,510 
Obligations under capital lease   57,363    40,701 
Accrued liabilities   670,625    379,675 
Deferred revenue   –    200,000 
           
Total current liabilities   2,173,752    2,431,219 
           
Obligations under capital lease, long-term   23,874    48,559 
           
Convertible notes payable, long-term   1,568,550    – 
Total liabilities   3,766,176    2,479,778 
           
Commitments and contingencies   –    – 
           
Stockholders' equity (deficit):          
Preferred stock, $1.00 par value, 2,000,000 shares authorized;
No shares issued and outstanding		   –    – 
Common stock, $.00l par value, 160,000,000 shares authorized,
119,505,007 and 118,915,698 shares issued and outstanding at
September 30, 2012 and December 31, 2011, respectively		   119,505    118,916 
Additional paid-in capital   115,197,203    114,654,026 
Accumulated deficit   (117,260,066)   (112,856,253)
           
Total stockholders’ equity (deficit)   (1,943,358)   1,916,689 
           
Total liabilities and stockholders’ equity (deficit)  $1,822,818   $4,396,467 

 

See notes to consolidated financial statements.

 

3
 

 

APPLIED NANOTECH HOLDINGS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

  

     For the Three Months Ended September 30,    For the Nine Months Ended September 30, 
    2012    2011    2012    2011 
Revenues                    
Government contracts  $436,729   $284,025   $1,223,273   $2,616,661 
Contract research   98,888    242,782    250,242    1,086,381 
License fees and royalties   109,000    1,608,103    887,896    1,870,943 
Product sales   54,543    23,480    189,031    89,236 
Other   6,345    90,629    62,150    185,313 
          Total revenues   705,505    2,249,019    2,612,592    5,848,534 
                     
Research and development   944,119    1,434,599    3,674,390    4,428,239 
Selling, general and administrative expenses   875,638    792,070    3,024,070    2,247,766 
                     
Operating costs and expenses   1,819,757    2,226,669    6,698,460    6,676,005 
                     
Income (Loss) from operations   (1,114,252)   22,350    (4,085,868)   (827,471)
                     
Other income (expense), net                    
Interest expense   (131,565)   (86,238)   (319,528)   (296,809)
Interest income   8    1,822    1,583    15,298 
                     
Loss from operations before taxes   (1,245,809)   (62,066)   (4,403,813)   (1,108,982)
                     
Provision for taxes   –    –    –    – 
                     
Net loss  $(1,245,809)  $(62,066)  $(4,403,813)  $(1,108,982)
                     
Earnings (loss) per share                    
                     
Basic and Diluted  $(0.01)  $(0.00)  $(0.04)  $(0.01)
                     
Weighted average shares outstanding                    
                     
Basic   119,381,717    118,853,585    119,194,845    116,155,990 
                     
Diluted   119,381,717    118,853,585    119,194,845    116,155,990 

 

See notes to consolidated financial statements.

 

4
 

 

APPLIED NANOTECH HOLDINGS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

 

   For the Nine Months Ended
September 30,		 
   2012   2011 
Cash flows from operating activities:          
Net loss  $(4,403,813)  $(1,108,982)
Adjustments to reconcile net loss to netcash used in operating activities:          
Depreciation and amortization expense   83,037    50,084 
Amortization of discount on debt   274,815    190,089 
Stock based compensation expense   215,291    564,908 
Changes in assets and liabilities:          
Accounts receivable, trade   403,915    (174,692)
Prepaid expenses and other assets   (545,706)   (78,108)
Accounts payable and accrued liabilities   812,381    (134,572)
Deferred revenue   (200,000)   (314,250)
           
Total adjustments   1,043,733    103,459 
           
Net cash used in operating activities   (3,360,080)   (1,005,523)
           
Cash flows from investing activities:          
Purchases of property and equipment   (50,398)   (70,611)
Net cash used in investing activities   (50,398)   (70,611)
           
Cash flows from financing activities:          
Repayment of capital leases   (36,590)   (17,602)
Proceeds from long-term debt   735,700    – 
Proceeds from stock issuance, net of costs   –    2,551,751 
           
Net cash provided by financing activities   699,110    2,534,149 
           
Net increase (decrease) in cash and cash equivalents   (2,711,368)   1,458,015 
           
Cash and cash equivalents, beginning of period   3,071,783    2,732,570 
           
Cash and cash equivalents, end of period  $360,415   $4,190,585 

 

See notes to consolidated financial statements.

 

5
 

APPLIED NANOTECH HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

1.       Basis of Presentation

 

The consolidated financial statements for the three and nine month periods ended September 30, 2012 and 2011 have been prepared by us without audit pursuant to the rules and regulations of the Securities and Exchange Commission. In the opinion of management, all adjustments necessary to present fairly our financial position, results of operations, and cash flows as of September 30, 2012 and 2011, and for the periods then ended, have been made. Those adjustments consist of normal and recurring adjustments. The consolidated balance sheet as of December 31, 2011, has been derived from the audited consolidated balance sheet as of that date.

 

Certain information and note disclosures normally included in our annual financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted. These consolidated financial statements should be read in conjunction with a reading of the financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2011, as filed with the U.S. Securities and Exchange Commission.

 

The results of operations for the three and nine month periods ended September 30, 2012, are not necessarily indicative of the results to be expected for the full year.

 

2.       Supplemental Cash Flow Information

 

Cash paid for interest for the nine months ended September 30, 2012 and 2011, was $18,676 and $3,504, respectively. During the nine months ended September 30, 2012 and 2011, the Company had non-cash transactions related to share based payments described in greater detail in Note 5 and non-cash transactions related to the conversion of notes payable and related accrued interest into common stock that are described in greater detail in Note 3. In addition, $120,000 of accounts payable were converted into common stock in each of 2012 and 2011, respectively. The Company also had capital lease transactions in the nine months ended September 30, 2012 and 2011 in the amounts of $28,567 and $85,369, respectively.

 

3.       Notes Payable and Long-Term Debt

 

We issued convertible notes payable in 2009 and 2010. These notes bear interest at a rate of 8% and were due in 2012. The notes and resulting accrued interest are convertible into shares of our common stock at rates of $0.20 to $0.25 per share. The face amount of the notes due was $2,146,000, and we valued the conversion rights at $647,250, which was recorded as a discount at the time of issuance. This discount was amortized to interest expense over the term of the notes. $216,000 of these notes were issued to officers and directors of the Company. As of September 30, 2012, a total of $526,000 of these notes have been converted to common stock, leaving a remaining principal balance as of that date of $1,620,000. Of these remaining notes, $900,000 were formally extended to 2014 and the remaining $720,000 were informally extended and reflected as current on the balance sheet. During the nine months ended September 30, 2011, a total of $326,000 of principal and related accrued interest of $31,394 was converted into 1,764,144 shares of common stock. During the nine months ended September 30, 2012, an additional $735,700 of convertible notes payable, bearing interest at 8%, were issued. These notes and the related accrued interest are convertible into common stock at a rate of $0.16 per share and due in January, 2014. The value of the conversion rights were valued at $208,475, which was recorded as a discount and is being amortized over the term of the notes.

 

4.       Stockholders’ Equity

 

During the nine months ended September 30, 2011, we issued 6,578,948 restricted shares of common stock and received proceeds of $2.5 million in an exempt offering under Regulation D of the Securities Act of 1933, and 200,454 shares for total proceeds of $51,751 in connection with the exercise of options by former employees. We also issued 300,752 shares of restricted common stock in payment of accounts payable in the amount of $120,000 during the same period, as well as 103,772 shares in connection with restricted stock payments to employees.

 

During the nine months ended September 30, 2012, we issued 494,949 shares of common stock in payment of accounts payable in the amount of $120,000, and 94,360 shares in connection with restricted stock payments to employees.

 

6
 

APPLIED NANOTECH HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

5. .       Share-Based Payments

 

We use the fair value method to account for stock based compensation. We recorded $215,291 and $564,908 in compensation expense in the periods ended September 30, 2012 and 2011, respectively, related to options and restricted stock issued under our stock-based incentive compensation plans. This includes expense related to both options issued and committed, as well as unissued restricted stock in the current year, and options issued in prior years for which the requisite service period for those options includes the current year. The fair value of these options was calculated using the Black-Scholes option pricing model. Information related to the assumptions used in this model is set forth in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2011. For options issued in 2012, the same approximate assumptions were used.

 

6.       Contingencies

 

Litigation

 

The Company is a defendant in minor lawsuits described in greater detail in its 2011 Annual Report on Form 10-K. The Company expects any potential eventual payment to have no material effect on the financial statements.

 

 

 

 

7
 

ITEM 2: MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS

 

The following is management’s discussion and analysis of certain significant factors that have affected our financial position and operating results during the periods included in the accompanying consolidated financial statements.

 

FORWARD-LOOKING STATEMENTS

 

This Form 10-Q contains certain forward-looking statements that we believe are within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which are intended to be covered by the safe harbors created by such acts. For this purpose, any statements that are not statements of historical fact may be deemed to be forward-looking statements, including the statements under "Management's Discussion and Analysis of Financial Condition and Results of Operations" regarding our strategy, future operations, future expectations or future estimates, financial position and objectives of management. Those statements in this Form 10-Q containing the words "believes," "anticipates," "plans," "expects" and similar expressions constitute forward-looking statements, although not all forward-looking statements contain such identifying words. These forward-looking statements are based on our current expectations and are subject to a number of risks, uncertainties and assumptions relating to our operations, results of operations, competitive factors, shifts in market demand and other risks and uncertainties.

 

Although we believe that the assumptions underlying our forward-looking statements are reasonable, any of the assumptions could be inaccurate and actual results may differ from those indicated by the forward-looking statements included in this Form 10-Q. In light of the significant uncertainties inherent in the forward-looking statements included in this Form 10-Q, you should not consider the inclusion of such information as a representation by us or anyone else that we will achieve such results. Moreover, we assume no obligation to update these forward-looking statements to reflect actual results, changes in assumptions or changes in other factors affecting such forward-looking statements.

 

Nine months ended September 30, 2012 and 2011

 

OVERVIEW

 

We are primarily a nanotechnology company engaged in the development of technologies, based principally on our intellectual property. We generate revenues by performing research services, licensing our technology, and selling products based on our technology. During all periods presented, our primary revenues were earned as a result of reimbursed research expenditures and licensing of our technology. As more fully discussed in our Annual Report on Form 10-K for the year ended December 31, 2011, we expect to incur significant additional research and development expenses in 2012 to further develop and commercialize our technology. We are focused on commercializing our technology and obtaining sufficient revenue to cover our ongoing expenditures.

 

OUTLOOK

 

We expect our present cash balances, which were approximately $360,000 at September 30, 2012, when combined with expected revenue sources, to enable us to operate through the end of 2012. We expect to raise additional money to extend that period and we also expect to sign additional revenue generating contracts which will continue to extend this time period. If we do not receive the expected revenue sources as quickly as anticipated, we may be required to cut back on our commercialization activities, or raise additional funding beyond the amount currently planned.

 

We had a plan to achieve profitability in 2012, and that plan anticipated a loss in the first half, which was expected to be offset by profits for the balance of the year. Since developing this plan, we have accelerated spending on commercialization activities, including pursuing an acquisition opportunity. In addition, revenues from product sales have not increased as quickly as planned. That has made it unlikely that we can achieve profitability this year. A critical component of our plan is the receipt of additional revenues. These revenues must come from a variety of sources, including research revenues, license fees – either in the form of an upfront payment, or from ongoing royalties as a result of product sales by our licensees, and product sales by us.

 

8
 

ITEM 2: MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (cont.)

 

At the present time, there can be no assurance that expected revenue sources will all occur as planned. It is not possible for us to achieve profitability without license fees or royalties at our present level of activity. In order to achieve profitability solely based on research revenues, our research revenue would have to more than double from our expected level for 2012, and the majority of the revenue would have to come from non-governmental sources. The mix of revenues received could also cause the revenues required to reach break-even to increase. If revenue producing projects require unanticipated expenses, or heavier than anticipated use of outside services and materials, we may be unable to achieve profitability at the expected level of revenues.  We believe that we have the ability to continue to obtain funding, if necessary, to enable us to continue operations until we reach profitability.  

 

Our plan is based on current development plans, current operating plans, the current regulatory environment, historical experience in the development of electronic products and general economic conditions. Changes could occur which would cause certain assumptions on which this plan is based to be no longer valid. If adequate funds are not available from operations, or other sources of financing, we may have to eliminate, or reduce substantially, expenditures for research and development, testing and production of its products, or obtain funds through arrangements with other entities that may require us to relinquish rights to certain of our technologies or products. Such results could materially and adversely affect us.

 

RECENT DEVELOPMENTS

 

In October 2012, we amended our license agreement with Sichuan Anxian Yinhee Construction and Chemical Group to extend their exclusivity for our solar inks and pastes to a worldwide exclusive license. Under this amendment, we will receive an initial royalty payment of $500,000, of which $250,000 was received in October 2012, and $250,000 is payable in 2013 if we achieve certain technical specifications related to our silver paste. The original agreement contained a similar provision related to the specifications for aluminum pastes. Those specifications were achieved early this year and the payment tied to those specifications was received. We expect to achieve the specifications set forth for the silver paste and receive the contingent payment in 2013. In addition, if these specifications are achieved, the royalty rate on running royalties under the agreement will be increased from 3% to 3.5%.

 

RECENT ACCOUNTING PRONOUNCEMENTS

 

There are no recent accounting pronouncements that we have not implemented that are expected to have a material impact on our financial statements.

 

FINANCIAL CONDITION AND LIQUIDITY

 

Our cash position decreased during the period from approximately $3.1 million at December 31, 2011 to approximately $360,000 at September 30, 2012. This decrease in cash is primarily the result of cash used in operating activities.

 

Our net cash used in operating activities increased from approximately $1.0 million in the 2011 Period to approximately $3.4 million in the 2012 Period. This is primarily the result of operating factors discussed below in the “Results of Operations”, as well as management of working capital items.

 

Cash used in investing activities in both periods was insignificant and related to the purchase of capital equipment. We expect cash used in investing activities to remain at relatively insignificant levels for the balance of 2012.

 

We had cash provided by financing activities in both periods. In 2012 we had cash generated from the issuance of notes payable in the amount of $735,700 and in 2011 we received approximately $2.6 million in proceeds from the issuance of common stock . There were insignificant amounts of cash used in financing activities in both periods related to payments on capital leases.

 

Historically, the principal source of our liquidity has been funds received from exempt offerings of common stock. We are currently seeking funds to accelerate our commercialization activities and to potentially facilitate a potential acquisition. While we expect to be able to obtain any funds needed for operations, there can be no assurance that any of these financing alternatives can be arranged on commercially acceptable terms. We believe that our success in reaching profitability will be dependent on our patent portfolio and upon the viability of products using our technology and their acceptance in the marketplace, as well as our ability to obtain additional debt or equity financings in the future, if needed.

 

9
 

ITEM 2: MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS (cont.)

 

We expect to continue to incur substantial expenses for research, development and commercialization activities. Further, we believe that certain products that may be developed by potential licensees of our technology may not be available for commercial sale or routine use for a period of one to two years. Others are expected to be available in 2012 and 2013. While we would likely receive initial license payments, ongoing royalty streams related to some licenses may not be available until potential licensees have introduced products using our technology. Therefore, it is possible that the commercialization of our existing and proposed products may require additional capital in excess of our current funding. We did, however, have a plan to operate profitably in 2012 based on the receipt of research funding, license agreements, product sales, and other revenues. However, our accelerated spending on commercialization activities, including a potential acquisition, has made it unlikely that we will achieve profitability in 2012. Achievement of at least break-even would enable us to continue our research without seeking additional financing in the future.

 

Because the timing and receipt of revenues from product sales, or license and royalty agreements will be tied to the achievement of certain product development, testing and marketing objectives, which cannot be predicted with certainty, there may be substantial fluctuations in our results of operations. If revenues do not increase as rapidly as anticipated, or if product development and testing require more funding than anticipated, we may be required to curtail our operations or seek additional financing from other sources at some point in the future. The combined effect of the foregoing may prevent us from achieving sustained profitability for an extended period of time.

 

RESULTS OF OPERATIONS

 

Our net loss for the third quarter ended September 30, 2012 was approximately $1.2 million as compared with a net loss of approximately $60,000 for the same period last year. Our net loss of approximately $4.4 million for the nine months ended September 30, 2012 was increased from the loss of approximately $1.1 for the nine months ended September 30, 2011. This increased loss was the result of reasons set forth below.

 

Our revenues for the quarter ended September 30, 2012 totaled approximately $700,000 compared to approximately $2.25 million for the same quarter of 2011. For the nine-month period ended September 30, 2012 (the “2012 Period”), our revenues were approximately $2.6 million as compared with approximately $5.8 million for the nine-month period ended September 30, 2011 (the “2011 Period”). The largest source of revenues in the 2012 Period was from research services – approximately $1,474,000, of which approximately $1,223,000 of which was from government sources. This is a significant decrease from the 2011 Period and was the result of two main reasons. First, during 2011, we had a Phase 3 commercialization contract which resulted in $1.2 million in revenue in the 2011 Period. There was no such contract in 2012. In addition, we had significant research revenue from the NE Gas association in 2011, approximately $700,000, whereas we had only approximately $50,000 in revenue from the same source in 2012. In addition, certain research contracts that we expected to receive were delayed in 2012.

 

Our license fees and royalties decreased significantly in 2012. Of the total of approximately $888,000 in royalty revenue, $500,000 was from the remainder of the YHCC license signed in 2011. The balance of approximately $388,000 was from Yonex. The 2011 royalty revenues were $1.5 million from YHCC related to the solar inks license and the remaining $371,000 was from Yonex. We also had a significant increase in our product sales from 2011 to 2012, which is the result of our increased focus in this area. We expect product sales to continue to grow throughout the remainder of the year.

 

We have a research revenue backlog of approximately $2.4 million as of the date of this filing, as compared to our backlog of approximately $1.7 million as of September 30, 2011, and $2.3 million at December 31, 2011. We have several quotes in process and we expect to land additional research contracts and we expect our research revenue to increase during the fourth quarter of 2012. Our ability to perform continued research, or fulfill our backlog, will not require additional personnel. We do not anticipate hiring any additional people for research purposes for the balance of the year, unless we receive significant new revenues.

 

10
 

ITEM 2: MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS (cont.)

 

At the present stage of our development, significant conclusions cannot be drawn by comparing revenues from period to period; however, we would expect the quarterly revenue for the balance of 2012 to increase above the level of the first three quarters. We are currently behind our revenue plan for 2012 and likely will not be able to make up the shortfall, particularly in the research area; however, our plan anticipated increased revenues in the third and fourth quarters. At our present pace, we would expect revenues to be approximately $4.0 million for 2012; however, we have potential agreements that, if completed, would increase that amount. Our business strategy is built on commercializing our technology through product sales and developing a royalty stream from licensing our intellectual property. To supplement this, we also seek funding from both governmental and private sources to help fund our research. Until we are able to develop a steady revenue stream from royalties, or product sales, our revenues will tend to fluctuate greatly from quarter to quarter. Our private research funding tends to come in large amounts at sporadic times.

 

We incurred research and development expenses of approximately $3.7 million in the 2012 Period, which was down from the amount of approximately $4.4 million incurred in the 2011 Period. This decrease in research expenses is a direct result of the decreased research revenue in 2012. The decrease in expense was less than the decrease in research revenue since some of the expenses are fixed and a portion of the labor previously devoted to funded projects is now devoted to unfunded commercialization development activities. In addition we have shifted some of our resources that were previously focused on R&D to the sales area as a result of our increased focus on commercialization. Significant new revenue producing research programs beyond those already identified could, however, cause research and development expenditures to increase.

 

Our selling, general, and administrative expenses increased from approximately $2.2 million in 2011 to $3.0 million in 2012. The overwhelming majority of this increase, approximately $800,000, is the result of the formation of our sensor subsidiary and due diligence activities related to the potential acquisition for the subsidiary. The balance of the increase is primarily related to increased selling expenses related to other areas of our business, partially offset by cost reductions in other administrative areas.

 

Our interest income is insignificant in both periods. Our interest income results from the investment of excess funds in short term interest bearing instruments, primarily certificates of deposit, commercial paper, and money market funds. We expect our interest income to remain at insignificant levels for the balance of 2012. Our interest expense, which is primarily the result of our convertible notes payable, increased slightly in the 2012 Period. This interest expense includes both the stated interest rate on the debt and the amortization of the discount associated with the notes. We would expect our interest expense to remain at similar levels for the fourth quarter of 2012.

 

ITEM 3.       Quantitative and Qualitative disclosures about market risk

 

We do not use any derivative financial instruments for hedging, speculative, or trading purposes. Our exposure to market risk is currently immaterial.

 

ITEM 4.       Controls and Procedures

 

Under the supervision of and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as of the end of the period covered by this report (the "Evaluation Date"). Based upon this evaluation, our principal executive officer and principal financial officer concluded as of the Evaluation Date that our disclosure controls and procedures were effective such that the material information required to be included in our Securities and Exchange Commission ("SEC") reports is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms relating to the Company, including, our consolidated subsidiaries, and was made known to them by others within those entities, particularly during the period when this report was being prepared.

 

In addition, there were no significant changes in our internal controls over financial reporting or in other factors that could significantly affect these controls subsequent to the Evaluation Date. We have not identified any material weaknesses in our internal controls, and therefore, no corrective actions were taken.

 

11
 

 

PART II. OTHER INFORMATION

 

ITEM 6.     EXHIBITS

 

Exhibits: See Index to Exhibits on page 14 for a descriptive response to this item.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

12
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

APPLIED NANOTECH HOLDINGS, INC.

(Registrant)

   
Date:     November 2, 2012 /s/ Douglas P. Baker
 

Douglas P. Baker

Chief Executive Officer, Chief Financial Officer

(Principal Executive Officer, Principal Financial

Officer, and Principal Accounting Officer)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

13
 

 

INDEX TO EXHIBITS

 

The following documents are filed as part of this Report:

 

Exhibit  
   
11 Computation of (Loss) Per Common Share
   
31.1 Rule 13a-14(a)/15d-14(a) Certificate of Douglas P. Baker
   
32.1 Section 1350 Certificate of Douglas P. Baker
   
101.INS XBRL Instance Document
   
101.SCH XBRL Schema Document
   
101.CAL XBRL Calculation Linkbase Document
   
101.DEF XBRL Definition Linkbase Document
   
101.LAB XBRL Label Linkbase Document
   
101.PRE XBRL Presentation Linkbase Document

 

  

  

 

 

 

 

 

 

 

 

 

 

 

 

 

14

 

 EX-11 2 apnt_10q-ex1100.htm COMPUTATION OF LOSS

 

Exhibit 11

 

Applied Nanotech Holdings, Inc.

 

Computation of Income (Loss) Per Share

 

   Three Months ended Sept. 30,   Nine Months ended Sept. 30, 
   2012   2011   2012   2011 
                 
Computation of loss per common share:                    
                     
Net loss applicable to common  shares  $(1,245,809)  $(62,066)  $(4,403,813)  $(1,108,982)
                     
Weighted average number of common shares   119,381,717    118,853,585    119,194,845    116,155,990 
                     
Net income (loss) per common share  $(0.01)  $(0.00)  $(0.04)  $(0.01)

 

 

 

 

 

 

 

** No computation of diluted loss per common share is included for the other periods because such computation results in an antidilutive loss per common share.

 EX-31.1 3 apnt_10q-ex3101.htm CERTIFICATION

 

Exhibit 31.1

 

Certificate of Chief Executive Officer and Chief Financial Officer
Pursuant to Rule 13a-14(a)/15d-14(a)

 

I, Douglas P. Baker, certify that:

 

1.             I have reviewed this quarterly report on Form 10-Q for the quarter ended September 30, 2012 of Applied Nanotech Holdings, Inc. (“APNT”);

 

2.             Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.             Based on my knowledge, the financial statements, and other financial information included in this report, fairly present, in all material respects, the financial condition, results of operations and cash flows of APNT as of, and for, the periods presented in this report.

 

4.             APNT’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in the Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting )as defined in the Exchange Act Rules 13a – 15(f) and 15d – 15(f)) for APNT and have:

 

(a)        Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to APNT, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)           Evaluated the effectiveness of APNT’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)           Disclosed in this report any change in APNT’s internal control over financial reporting that occurred during APNT’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, APNT’s internal control over financial reporting; and

 

5.             APNT’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to APNT’s auditors and the audit committee of APNT’s board of directors:

 

(a)         All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect APNT’s ability to record, process, summarize and report financial information; and

 

(b)          Any fraud, whether or not material, that involves management or other employees who have a significant role in APNT’s internal control over financial reporting. 

 

Date:    November 2, 2012

 

/s/Douglas P. Baker

 

Douglas P. Baker

Chief Executive Officer and Chief Financial Officer

 

 EX-32.1 4 apnt_10q-ex3201.htm CERTIFICATION

 

EXHIBIT 32.1

 

Section 1350 Certification of Chief Executive Officer and Chief Financial Officer

 

In connection with the quarterly report of Applied Nanotech Holdings, Inc. (the “Company”) on Form 10-Q for the quarter ended September 30, 2012, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Douglas P. Baker, the Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

1.     The Report fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934; and

 

2.     The information contained in this Report fairly presents, in all material respects, the financial conditions and results of operations of the Company as of the dates and for the periods expressed in the report.

 

 

Date:       November 2, 2012 /s/ Douglas P. Baker
 

Douglas P. Baker

Chief Executive Officer and Chief Financial Officer

 

 EX-101.INS 5 apnt-20120930.xml XBRL INSTANCE FILE 0000891417 2012-01-01 2012-09-30 0000891417 2012-09-30 0000891417 2011-12-31 0000891417 2010-12-31 0000891417 2011-09-30 0000891417 2012-07-01 2012-09-30 0000891417 2011-07-01 2011-09-30 0000891417 2011-01-01 2011-09-30 0000891417 APNT:OfficersAndDirectorsMember 2010-12-31 0000891417 2012-10-31 0000891417 APNT:Second2012NoteMember 2012-01-01 2012-09-30 0000891417 APNT:Second2012NoteMember 2012-09-30 0000891417 APNT:ConvertibleNote2010Member 2010-12-31 0000891417 APNT:ConvertibleNote2010Member 2012-01-01 2012-09-30 0000891417 APNT:ConvertibleNote2010Member 2012-09-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure Applied Nanotech Holdings, Inc. 0000891417 10-Q 2012-09-30 false --12-31 No No No Smaller Reporting Company Q3 2012 119675372 1495244 4064667 298983 303055 1822818 4396467 725764 324333 720000 1486510 57363 40701 2173752 2431219 23874 48559 3766176 2479778 119505 118916 115197203 114654026 435948 839863 200000 1568550 -1943358 1916689 1822818 4396467 698881 153021 28591 28745 -117260066 -112856253 1.00 1.00 2000000 2000000 0 0 0 0 .001 .001 160000000 160000000 119505007 118915698 119505007 118915698 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The consolidated financial statements for the three and nine month periods ended September 30, 2012 and 2011 have been prepared by us without audit pursuant to the rules and regulations of the Securities and Exchange Commission. In the opinion of management, all adjustments necessary to present fairly our financial position, results of operations, and cash flows as of September 30, 2012 and 2011, and for the periods then ended, have been made. Those adjustments consist of normal and recurring adjustments. The consolidated balance sheet as of December 31, 2011, has been derived from the audited consolidated balance sheet as of that date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Certain information and note disclosures normally included in our annual financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted. These consolidated financial statements should be read in conjunction with a reading of the financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2011, as filed with the U.S. Securities and Exchange Commission.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The results of operations for the three and nine month periods ended September 30, 2012, are not necessarily indicative of the results to be expected for the full year.</p> <p style="margin: 0pt"><font style="font-size: 10pt">Cash paid for interest for the nine months ended September 30, 2012 and 2011, was $18,676 and $3,504, respectively. During the nine months ended September 30, 2012 and 2011, the Company had non-cash transactions related to share based payments described in greater detail in Note 5 and non-cash transactions related to the conversion of notes payable and related accrued interest into common stock that are described in greater detail in Note 3. In addition, $120,000 of accounts payable were converted into common stock in each of 2012 and 2011, respectively. The Company also had capital lease transactions in the nine months ended September 30, 2012 and 2011 in the amounts of $28,567 and $85,369, respectively.</font></p> 3504 18676 120000 120000 85369 28567 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">During the nine months ended September 30, 2011, we issued 6,578,948 restricted shares of common stock and received proceeds of $2.5 million in an exempt offering under Regulation D of the Securities Act of 1933, and 200,454 shares for total proceeds of $51,751 in connection with the exercise of options by former employees. We also issued 300,752 shares of restricted common stock in payment of accounts payable in the amount of $120,000 during the same period, as well as 103,772 shares in connection with restricted stock payments to employees.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">During the nine months ended September 30, 2012, we issued 494,949 shares of common stock in payment of accounts payable in the amount of $120,000, and 94,360 shares in connection with restricted stock payments to employees.</p> <p style="margin: 0pt"><font style="font-size: 10pt">We use the fair value method to account for stock based compensation. We recorded $215,291 and $564,908 in compensation expense in the periods ended September 30, 2012 and 2011, respectively, related to options and restricted stock issued under our stock-based incentive compensation plans. This includes expense related to both options issued and committed, as well as unissued restricted stock in the current year, and options issued in prior years for which the requisite service period for those options includes the current year. The fair value of these options was calculated using the Black-Scholes option pricing model. Information related to the assumptions used in this model is set forth in the Company&#146;s Annual Report on Form 10-K for the fiscal year ended December 31, 2011. For options issued in 2012, the same approximate assumptions were used.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Litigation</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company is a defendant in minor lawsuits described in greater detail in its 2011 Annual Report on Form 10-K. The Company expects any potential eventual payment to have no material effect on the financial statements.</p> 6578948 2500000 200454 51751 494949 300752 120000 120000 94360 103722 215291 564908 <p style="margin: 0pt"><font style="font-size: 10pt">We issued convertible notes payable in 2009 and 2010. These notes bear interest at a rate of 8% and were due in 2012. The notes and resulting accrued interest are convertible into shares of our common stock at rates of $0.20 to $0.25 per share. The face amount of the notes due was $2,146,000, and we valued the conversion rights at $647,250, which was recorded as a discount at the time of issuance. This discount was amortized to interest expense over the term of the notes. $216,000 of these notes were issued to officers and directors of the Company. As of September 30, 2012, a total of $526,000 of these notes have been converted to common stock, leaving a remaining principal balance as of that date of $1,620,000. Of these remaining notes, $900,000 were formally extended to 2014 and the remaining $720,000 were informally extended and reflected as current on the balance sheet. During the nine months ended September 30, 2011, a total of $326,000 of principal and related accrued interest of $31,394 was converted into 1,764,144 shares of common stock. During the nine months ended September 30, 2012, an additional $735,700 of convertible notes payable, bearing interest at 8%, were issued. These notes and the related accrued interest are convertible into common stock at a rate of $0.16 per share and due in January, 2014. The value of the conversion rights were valued at $208,475, which was recorded as a discount and is being amortized over the term of the notes.</font></p> .08 .08 2014-01-31 2014-12-31 .16 .20 216000 735000 2146000 208475 647250 326000 526000 31394 1764144 .25 670625 379675 -4403813 -1245809 -62066 -1108982 -4403813 -1245809 -62066 -1108982 1583 8 1822 15298 319528 131565 86238 296809 -4085868 -1114252 22350 -827471 6698460 1819757 2226669 6676005 3024070 875638 792070 2247766 3674390 944119 1434599 4428239 2612592 705505 2249019 5848534 62150 6345 90629 185313 189031 54543 23480 89236 887896 109000 1608103 1870943 250242 98888 242782 1086381 1223273 436729 284025 2616661 -0.04 -0.01 -0.00 -0.01 119194845 119381717 118853585 116155990 119194845 119381717 118853585 116155990 360415 3071783 2732570 4190585 -2711368 1458015 699110 2534149 2551751 735700 36590 17602 -50398 -70611 50398 70611 3360080 1005523 1043733 103459 -200000 -314250 -812381 134572 -545706 -78108 403915 -174692 -215291 -564908 -274815 -190089 -83037 -50084 1620000 EX-101.SCH 6 apnt-20120930.xsd XBRL SCHEMA FILE 0001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 0002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 0003 - Statement - Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0004 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 0005 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 0006 - Disclosure - 1. Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 0007 - Disclosure - 2. Supplemental Cash Flow Information link:presentationLink link:calculationLink link:definitionLink 0008 - Disclosure - 3. Notes Payable and Long-Term Debt link:presentationLink link:calculationLink link:definitionLink 0009 - Disclosure - 4. Stockholders Equity link:presentationLink link:calculationLink link:definitionLink 0010 - Disclosure - 5. Share-Based Payments link:presentationLink link:calculationLink link:definitionLink 0011 - Disclosure - 6. Contingencies link:presentationLink link:calculationLink link:definitionLink 0012 - Disclosure - 2. Supplemental Cash Flow Information - 2. Supplemental Cash Flow Information (Details) link:presentationLink link:calculationLink link:definitionLink 0013 - Disclosure - 3. Notes Payable and Long-Term Debt (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 0014 - Disclosure - 4. Stockholders Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 0015 - Disclosure - 5. Share-Based Payments (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 apnt-20120930_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 apnt-20120930_def.xml XBRL DEFINITION FILE EX-101.LAB 9 apnt-20120930_lab.xml XBRL LABEL FILE Officers And Directors Debt Instrument [Axis] Second 2012 Note Convertible Note 2010 Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Is Entity a Well-known Seasoned Issuer? Is Entity a Voluntary Filer? Is Entity's Reporting Status Current? Entity Filer Category Entity Public Float Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS Current assets: Cash and cash equivalents Accounts receivable - net of allowance for doubtful accounts Prepaid expenses and other current assets Total current assets Property and equipment, net Other assets Total assets LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) Current liabilities: Accounts payable Convertible notes payable Obligations under capital lease Accrued liabilities Deferred revenue Total current liabilities Obligations under capital lease, long-term Convertible notes payable, long-term Total liabilities Commitments and contingencies Stockholders' equity (deficit): Preferred stock, $1.00 par value, 2,000,000 shares authorized; No shares issued and outstanding Common stock, $.00l par value, 160,000,000 shares authorized, 119,505,007 and 118,915,698 shares issued and outstanding at September 30, 2012 and December 31, 2011, respectively Additional paid-in capital Accumulated deficit Total stockholders' equity (deficit) Total liabilities and stockholders' equity (deficit) Preferred stock par value Preferred stock shares authorized Preferred stock shares issued Preferred stock shares outstanding Common stock par value Common stock shares authorized Common stock shares issued Common stock shares outstanding Income Statement [Abstract] Revenues Government contracts Contract research License fees and royalties Product sales Other Total revenues Research and development Selling, general and administrative expenses Operating costs and expenses Income (Loss) from operations Other income (expense), net Interest expense Interest income Loss from continuing operations before taxes Provision for taxes Net loss Earnings (loss) per share - Basic and Diluted Weighted average shares outstanding Basic Diluted Statement of Cash Flows [Abstract] Net loss Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization expense Amortization of discount on debt Stock based compensation expense Changes in assets and liabilities: Accounts receivable, trade Prepaid expenses and other assets Accounts payable and accrued liabilities Deferred revenue Total adjustments Net cash used in operating activities Cash flows from investing activities: Purchases of property and equipment Net cash used in investing activities Cash flows from financing activities: Repayment of capital leases Proceeds from long-term debt Proceeds from stock issuance, net of costs Net cash provided by financing activities Net increase (decrease) in cash and cash equivalents Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Accounting Policies [Abstract] 1. Basis of Presentation Supplemental Cash Flow Elements [Abstract] 2. Supplemental Cash Flow Information Debt Disclosure [Abstract] 3. Notes Payable and Long-Term Debt Equity [Abstract] 4. Stockholders Equity Disclosure of Compensation Related Costs, Share-based Payments [Abstract] 5. Share-Based Payments Commitments and Contingencies Disclosure [Abstract] 6. Contingencies Notes to Financial Statements Cash paid for interest Accounts payable converted into common stock Capital lease transaction Statement [Table] Statement [Line Items] Stated interest rate Maturity date Conversion price per share minimum Conversion of stock per share maximum Face amount Debt discount Amount converted Note payable balance Accrued interest Shares converted Restricted stock issued Restricted stock proceeds Exercise of options by former employees Stock options exercised by former employees Stock issued for conversion of accounts payable-shares Stock issued for conversion of accounts payable Restricted stock issued to employees Share-based compensation Assets, Current Assets Liabilities, Current Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Revenues [Default Label] Operating Costs and Expenses Operating Income (Loss) Interest Expense Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest Depreciation, Depletion and Amortization, Nonproduction Amortization of Financing Costs and Discounts Share-based Goods and Nonemployee Services Transaction, Cash Flow Effects Increase (Decrease) in Accounts Payable and Accrued Liabilities Deferred Revenue, Period Increase (Decrease) Increase (Decrease) in Operating Assets Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities Repayments of Debt and Capital Lease Obligations Net Cash Provided by (Used in) Financing Activities Cash and Cash Equivalents, Period Increase (Decrease) Accounts payable converted to common stock Debt instrument convertible conversion price Document and entity information abstract notes to financial statement abstract officers and directors member restricted stock issued to employees second 2012 note member Convertible note issued in 2010 EX-101.PRE 10 apnt-20120930_pre.xml XBRL PRESENTATION FILE XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 R9.htm IDEA: XBRL DOCUMENT v2.4.0.6
4. Stockholders Equity
 9 Months Ended
Sep. 30, 2012
Equity [Abstract]  
4. Stockholders Equity

During the nine months ended September 30, 2011, we issued 6,578,948 restricted shares of common stock and received proceeds of $2.5 million in an exempt offering under Regulation D of the Securities Act of 1933, and 200,454 shares for total proceeds of $51,751 in connection with the exercise of options by former employees. We also issued 300,752 shares of restricted common stock in payment of accounts payable in the amount of $120,000 during the same period, as well as 103,772 shares in connection with restricted stock payments to employees.

 

During the nine months ended September 30, 2012, we issued 494,949 shares of common stock in payment of accounts payable in the amount of $120,000, and 94,360 shares in connection with restricted stock payments to employees.
EXCEL 13 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%]B-S-A,#,U,E\Y,65C7S1E-V9?.#(S,5\W9#8S M93$Y8C`S,SDB#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/D-O;G-O;&ED871E9%]3 M=&%T96UE;G1S7V]F7T]P93PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-O;G-O;&ED871E9%]3=&%T96UE;G1S7V]F7T-A#I. M86UE/@T*("`@(#QX.E=O#I% M>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O6UE;G1S M/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I%>&-E M;%=O#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/C-?3F]T97-?4&%Y86)L95]A M;F1?3&]N9U1E#I7;W)K#I3='EL97-H965T($A2968],T0B5V]R:W-H965T3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]B-S-A,#,U M,E\Y,65C7S1E-V9?.#(S,5\W9#8S93$Y8C`S,SD-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO8C'0O:'1M;#L@8VAA2!) M;F9O2!);F9O'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$"!+97D\+W1D/@T*("`@("`@("`\=&0@8VQA'0^4V5P(#,P+`T*"0DR M,#$R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^9F%L2!A(%=E;&PM:VYO=VX@4V5A'0^3F\\2!A(%9O;'5N=&%R>2!& M:6QE'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!A;F0@ M97%U:7!M96YT+"!N970\+W1D/@T*("`@("`@("`\=&0@8VQA6%B M;&4\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)FYB'0^)FYBF5D+"`Q,3DL-3`U+#`P-R!A;F0@,3$X+#DQ-2PV.3@@2`H9&5F:6-I="D\+W1D/@T*("`@("`@("`\ M=&0@8VQA'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQAF5D/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$;G5M<#XR+#`P,"PP,#`\3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]B-S-A M,#,U,E\Y,65C7S1E-V9?.#(S,5\W9#8S93$Y8C`S,SD-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO8C'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$6%L=&EE&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q+#(T-2PX,#DI M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S M<#L\7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$;G5M<#XX,RPP,S<\'0^)FYB3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]B-S-A,#,U,E\Y,65C7S1E-V9?.#(S M,5\W9#8S93$Y8C`S,SD-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO M8C'0O:'1M;#L@8VAA M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M:6YD96YT.B`P+C5I;B<^5&AE(&-O;G-O;&ED871E9"!F M:6YA;F-I86P@2!T M;R!P0T*;W5R(&9I;F%N8VEA;"!P;W-I=&EO;BP@6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M:6YD96YT.B`P+C5I;B<^0V5R=&%I;B!I;F9O65A6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE'0M:6YD96YT M.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'!E8W1E9"!F;W(@=&AE M(&9U;&P@>65A3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%]B-S-A,#,U,E\Y,65C7S1E-V9?.#(S,5\W9#8S93$Y8C`S M,SD-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8C'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^/'`@6QE M/3-$)V9O;G0M2X@1'5R:6YG('1H92!N:6YE(&UO;G1H6%B;&4@86YD(')E;&%T960@86-C6%B;&4@=V5R92!C;VYV97)T960@:6YT;R!C;VUM;VX@ M2X\+V9O;G0^/"]P/CQS<&%N/CPO7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA6%B;&4@ M86YD($QO;F2X@07,@;V8@4V5P M=&5M8F5R(#,P+"`R,#$R+"!A('1O=&%L#0IO9B`D-3(V+#`P,"!O9B!T:&5S M92!N;W1E2!E>'1E;F1E9"!T;R`R,#$T M(&%N9"!T:&4@2!E M>'1E;F1E9"!A;F0@2P@,C`Q-"X@5&AE('9A;'5E(&]F('1H92!C;VYV97)S:6]N#0IR:6=H M=',@=V5R92!V86QU960@870@)#(P."PT-S4L('=H:6-H('=A'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA2!; M06)S=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M=&5X=#X\6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE'0M M:6YD96YT.B`P+C5I;B<^1'5R:6YG('1H92!N:6YE(&UO;G1H&5R8VES92!O9B!O M<'1I;VYS(&)Y#0IF;W)M97(@96UP;&]Y965S+B!792!A;'-O(&ES6%B;&4@:6X@=&AE(&%M;W5N="!O9B`D M,3(P+#`P,`T*9'5R:6YG('1H92!S86UE('!E7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6QE/3-$)VUAF4Z(#$P<'0G/E=E('5S92!T:&4@9F%I'!E;G-E(&EN('1H92!P97)I;V1S(&5N9&5D(%-E<'1E;6)E'!E;G-E(')E;&%T960@=&\@8F]T:`T*;W!T:6]N65A7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6%B;&4@8V]N=F5R=&5D(&EN=&\@8V]M;6]N M('-T;V-K/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,C`L,#`P M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA6%B;&4@86YD($QO;F'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S&EM=6T\+W1D M/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'10 M87)T7V(W,V$P,S4R7SDQ96-?-&4W9E\X,C,Q7S=D-C-E,3EB,#,S.0T*0V]N M=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]B-S-A,#,U,E\Y,65C7S1E-V9? M.#(S,5\W9#8S93$Y8C`S,SDO5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S65E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M&5R8VES960@8GD@ M9F]R;65R(&5M<&QO>65E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S65E'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\>&UL('AM;&YS.F\],T0B=7)N.G-C:&5M87,M M;6EC&UL/@T*+2TM+2TM/5].97AT4&%R=%]B-S-A,#,U,E\Y,65C7S1E-V9?.#(S 2,5\W9#8S93$Y8C`S,SDM+0T* ` end XML 14 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
3. Notes Payable and Long-Term Debt
 9 Months Ended
Sep. 30, 2012
Debt Disclosure [Abstract]  
3. Notes Payable and Long-Term Debt

We issued convertible notes payable in 2009 and 2010. These notes bear interest at a rate of 8% and were due in 2012. The notes and resulting accrued interest are convertible into shares of our common stock at rates of $0.20 to $0.25 per share. The face amount of the notes due was $2,146,000, and we valued the conversion rights at $647,250, which was recorded as a discount at the time of issuance. This discount was amortized to interest expense over the term of the notes. $216,000 of these notes were issued to officers and directors of the Company. As of September 30, 2012, a total of $526,000 of these notes have been converted to common stock, leaving a remaining principal balance as of that date of $1,620,000. Of these remaining notes, $900,000 were formally extended to 2014 and the remaining $720,000 were informally extended and reflected as current on the balance sheet. During the nine months ended September 30, 2011, a total of $326,000 of principal and related accrued interest of $31,394 was converted into 1,764,144 shares of common stock. During the nine months ended September 30, 2012, an additional $735,700 of convertible notes payable, bearing interest at 8%, were issued. These notes and the related accrued interest are convertible into common stock at a rate of $0.16 per share and due in January, 2014. The value of the conversion rights were valued at $208,475, which was recorded as a discount and is being amortized over the term of the notes.
XML 15 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Balance Sheets (USD $)
Sep. 30, 2012
Dec. 31, 2011
Current assets:    
Cash and cash equivalents $ 360,415 $ 3,071,783
Accounts receivable - net of allowance for doubtful accounts 435,948 839,863
Prepaid expenses and other current assets 698,881 153,021
Total current assets 1,495,244 4,064,667
Property and equipment, net 298,983 303,055
Other assets 28,591 28,745
Total assets 1,822,818 4,396,467
Current liabilities:    
Accounts payable 725,764 324,333
Convertible notes payable 720,000 1,486,510
Obligations under capital lease 57,363 40,701
Accrued liabilities 670,625 379,675
Deferred revenue    200,000
Total current liabilities 2,173,752 2,431,219
Obligations under capital lease, long-term 23,874 48,559
Convertible notes payable, long-term 1,568,550   
Total liabilities 3,766,176 2,479,778
Commitments and contingencies      
Stockholders' equity (deficit):    
Preferred stock, $1.00 par value, 2,000,000 shares authorized; No shares issued and outstanding      
Common stock, $.00l par value, 160,000,000 shares authorized, 119,505,007 and 118,915,698 shares issued and outstanding at September 30, 2012 and December 31, 2011, respectively 119,505 118,916
Additional paid-in capital 115,197,203 114,654,026
Accumulated deficit (117,260,066) (112,856,253)
Total stockholders' equity (deficit) (1,943,358) 1,916,689
Total liabilities and stockholders' equity (deficit) $ 1,822,818 $ 4,396,467
XML 16 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
1. Basis of Presentation
 9 Months Ended
Sep. 30, 2012
Accounting Policies [Abstract]  
1. Basis of Presentation

The consolidated financial statements for the three and nine month periods ended September 30, 2012 and 2011 have been prepared by us without audit pursuant to the rules and regulations of the Securities and Exchange Commission. In the opinion of management, all adjustments necessary to present fairly our financial position, results of operations, and cash flows as of September 30, 2012 and 2011, and for the periods then ended, have been made. Those adjustments consist of normal and recurring adjustments. The consolidated balance sheet as of December 31, 2011, has been derived from the audited consolidated balance sheet as of that date.

 

Certain information and note disclosures normally included in our annual financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted. These consolidated financial statements should be read in conjunction with a reading of the financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2011, as filed with the U.S. Securities and Exchange Commission.

 

The results of operations for the three and nine month periods ended September 30, 2012, are not necessarily indicative of the results to be expected for the full year.
ZIP 17 0001019687-12-003861-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001019687-12-003861-xbrl.zip M4$L#!!0````(`,F%8D%2NH]/6QH``/G!```1`!P`87!N="TR,#$R,#DS,"YX M;6Q55`D``QDQE%`9,910=7@+``$$)0X```0Y`0``[%U9=^.XE7Z?<_(?.$ZE MG[1P7UQ5G>.RJWH\764[MJL[\]2')B$):8I4N-A6?OW<"Y`4*%$225&NI;N3 MTW%$`/?#W2\`@F_^_CP/I$<2)S0*WYXH(_E$(J$7^32_/=P*'V@)/!/I8O(&UZ&D^BU=.7.R:GT$PE)[*91_%KZQ0TR M_"7Z0`,22^?1?!&0E,`#3NE4TD8:D8;#!L/^0D(_BC_?7I;#SM)T<3H>/ST] MC<+HT7V*XM^3D1$OCT1IOBDC:)X.E9E61G_\]/'.V]&YNZ0ADGJAAXY*7H%-/R]KI_B M.,Z8/2V:;K1$X@4-;8R/']QD-3("W-%^`PD\]=.R@]C8&/.'E::TMJG)F]*B MJ4_6VB7$&TVCQS$\&*-PAK(RU)2B>4PF6R&;8WA:-*1)I*N*M6M^O$71(4N& M4]==E!TF;O+`&NJ=@`,^',].O:D!MW9S=5]V2&W(3#!.6N*5G12F`:JTVG"E/:63"2F MB:U)0M%KG$CC8BAN*EX4IN0YE:C_]N1#',T+ M<+*21OQO9[BB7W8C84K39?EK^3OU\X66G5_^?/(C6JWM*+IB MO1FO=UZ1&]?2RZDM@/.1OXD"3"A.T=/\N)I.,=+JV48W<(U")YSWBKQ?Z5+\ M7@%0_)BS=#N?SY+KR3?+6^Z@TAHF%4]Z99(R!#)@*=\LD_()')5)\K?.)/D% MF*1\Z^:F'-/<5K[?^KY\O_5U^?Z<=>03.'9`72^F?KLCT-#''ZZBE'SGYE$WV9=1^$CBE#X$!.>.3[YS86^=\?<:*7<$@3^E_\6D_VV%@S\5Y6MP$[T' MABRD7-R?[RXV)#DG;I+%Y,=\M^04VA2#%8^J)'"T+>/?S=R8)%M)Y/QBC3K3 M`'PW6^CX]!%4:).WV/<*]TYPCW-3@UKP8!UCW:@"T0L21G,:[B.[GR_K=.L& M+IY7N-"`H3=`9H_(%O!G1;'^#--/#?X/^+&;>9\N"6+ M"()8..5G%CI2JQ]LDR@#'2]QP*4*H#%UG!USB M7'\_P&_-Y_H/K6H#&R-M)X<*UHX8_EU'KARI1I31?!Z%=VGD_<[#VW668N!' MQU>AN[8D)J'K90_RJ"CYQ*/`[.3MR>75!W`RBF-:AF:I%5GOH%9@*Y*GLR0A M:9)K1ST4/NT5%$PT!!SHZG3'4'7]S;AVU-8DB[W:721UV=1-TVI(\B:.(*-* MES-0_$TX8@F:[)A=,/#F==9_+:J MVHJ]+HOF1!H)7'-`XAL"WR#B>1&XU>3&7;J0]Q^HV)9J6*:HU[6C=\?02*ZJ MKFE:6PQKM4]O_,#<:85E-Y7#,37ACZ+;IJ%T!^4N:.H&'R'FD^N'@$[=%*K+ M0SVB86FF(+/=1`Z'U,QC6K@\T0W21^H^T("FE!S*&2C!-,M05T`VA^Y&O`D/ MP)0457':$-_"IZLH]`YDA&9;^EYYK.CT`JR1HMB&X1P`3.!I5]YHEFDJEEDK MIY;DFJF%Y5B6W8@<)EU7&[T&T4MA3; M42)T*W MQ"/T$4/\`=F\KAF.;F]F697!.R-HP@A;`B-[%;\DC"7JVWP6\Z=BVK8@+"=MI'(JGD2(9FJQVQ-,# M.U3;<`3JW8DURD2A)C`:$;LEJ4M#XK]WXQ"W3R!<9/,L<%/B@X?%3[@$I3: M^K2I0^@(LJG;ZAUDCRY+,>5UY["#T(&8&FI;SY@.=E5\Y466K1UXZKU$"RQ- M>8.K,09DOH=CZ<==-6%.,__0I\-JPJ8=J-YE"21I27)!$B^F"USC@?3]G9M0 M0`$>,"%ARE:7[P'>NP"&;+PI_T.0OEY(2;H,R-N3"70ZE11YD4KW=$X2Z8H\ M2;?1W`T'_(>!=$=B.GDMS=UX2L-3"9O*KR4D-:0A'E6$WT8]^F*:O[V?, M42510'UT*!)>1!%ZU`V`(OS`UFFE213_\%=%>PTYNY3.8D(DX(($Z2B1@$/I M3.*'^A*)``$?$"Q2?J91DP?L)@O6'H4AS=Q'(CT0$DH++'8@+$@/2RE+I"<* M]IFEDIOYD$`OLCC)W#"5TDA"JG$6D(1AP)%B,L4,&!?KI6C"&MP1+XOY4CFV M>/_LS=QP2B2VW)S@L(8<%%*$U<&@=+!B3*8H%;BRAA*WL#`)=D0N3T;2_2Q*2&4:*%V:I$@MC&+0 M=XES$+W`#OVI"2&2%I#OH"&,,Q*QP$ASN#IPP)U/3T$54) ME)J!9R+E3FSWR.G,325\/$*E'R]00QD%_J]C&L(/[GSQ^J\02%Z_..ES$F.) M)]%P@@)"?>'V%:5$\FGB!1$>7>3JSV48+*&U%V1H;=`35=$-PPR$6VN_I:E! M6]?SHMAGK$>3DZ;L%AT<$9Z@.OJL2<;V9:`GT*$+,#YFN0P"$S*^DX*+%+X$ M&AK-:0H=F?XD31Q*`J8>@`Z`81.7P8(^_\I"CTV>X7+9(\206W@Y$`,A#%;P MBEE'3,!:UWESQGG#SW!)0.$# M(<+2(WX>W8V:^)\_DDZC(ZEUA"7#61PI/7J+6`)B@.P:!%YZ:,K,P:<>D`!W MF.M+01[T`?2,/"^(Q_2Q$'@6<'$+!B M9F9;(GK[2!(>LL!"*W01C!AT MXC)OP=UB3-B*&`J;'4B7\$8I'V:[Y#["9W)\X"YA"IXEQ3HF\#46"+CYCN)`Q"`*@_P?J]HPLTIWUV3"C!/)"X0IQS'&GD8F;C>#*>R M)H"J(.\%<4#>'#&9>/DF:8"G*#8%0\/V@I?R3NZ<3P1PO5+M@6%:7,ML8Z"9 MSAHZ9L6H]H4YK)MT4X-<-^3+7&ZX8]O46'>>``$36:$21V]+N>[JAMV;1:9X M\J2.-'N[:/T<7J$Z]Y%0$O7!"B4_=-><:C\X6S.N,\X]1XTN^4FC7O3*-L`H M]AYN*BCV`+`M%W%KP^H,<'/'$+WARH"_LL*Z>=`32J@G(E&^WF,.#,L>.+J- M3BZ-*4M=^*M6Z`XK[CNOYP@KNA9QY!'BYTYS9$AS&@08IS#U!S__3.8++`8G MA.'+``^^W%#4TPS,14U1?>:Q$E)Q-&V0.VIYH!MZ`8IE$1$&@@H"0QE8AI(G M^"$1\GL<']#$'DT(3Q%YI'W@U3660H`,T`;1DA"H37\E/.CD'-*`OF6H`E,$ M3JV'MSP/P%8;X;$2;!CH/*`R'/Y*C@F^#,:S4U8*/!%<,4A`:;2!995(:N8J MRI!!*O,2",6K*?Z1"H3V]J&*]J$[.EB'L\TDNHJHH/`LT3%`! MV>;R675CE5Z8E$)NO#19S2<'1?[.R_RH]$_!>XP.([;X87VN9=$+6'#>:1 M3P(LE%9+:FLEG`LSG>=T,BXF^!UDP;H"(V!F3$'!UG.VY;5/[C5U\S4OE?+.9;FB@@<-=R%!GX`^XD8+J-J=?(0&:Y9<; M]%(9&FN[]UV`M!(;>WC-?>?[O`KI4.1N.SP%A5%#,=4":3@5SI9^9E+SHI\" ME=O>66S'T$H>[#AH^U606OY#;0#_::4MREQTH$*C?[;ZP?JT'\C!2E"T__ M^`AYZ9P%[&C!QKZ8N]JFHAQ.L9O']Y"SN++(4T!``'RQ41ZI,J:.^(>!!2GO M7=29GKCBDY:H$"S;R%0'4-.M5H&>""]+_?4=OYA.9YC"85-9\J$TZN!KBDD=_+S*;K%S&6HMV=4AI=4NY-H>Y`#W#Q^96@#WYBX-A=,GD.`7IX76S@GQ MM;N!R5?O1@S(=4%\-0Z#,9!>.3+?*65\F!0G:<#^>$T.F&!>.F,'7^0H!GAE MJ4+/_*!.I2_7[4G`#AEPU4S*U8Z\7JD<>6J[+ZZ4[&:3UE:L7G%)V'8NMH*K M)L9Z*@/-T?G:2G536!E8I@Y&H&]95FV]E3_(SW>4N]6`\96E&0.+(]_JB@;, MVR"IE7=(P<4,1!6NNJ>5T"K;[ODF]"X74]U,$7T:.!+%7#D2;B?Q!'_!US"YSV#HZZUQ^_97-JSC+;O/;/`%O5]$V M@]'O!/;?1?PE9O')37%G;MGB+KHMMV:C_O)O;6U#*=+J']5VOG)H^?5YAT(3 MR)R7IGD#*2Y1#E#;7:]OB%<@-,;2ZR3:J.ZNF:AR[S/Y`-G8&4_&=@#?\:V, MW26#N?9>?CWI0R`V5Y#UBZ8TX^C@6@I^@WUZ'_S[')9AZJ*(8GTR$F(GA,YM M*&NH]P+W,-9"K:`:6SG;`/.N-8V5!>*>3@E/.,310_FKJ6;C19:]@(X^NW8! M9V?9?\QYKV<%7HR'HLYX!ELD";U(3X'4?WLV4DNWU>+H$72P_G4MJ%04O>DB M>V.!L+6OIB%./6K,-?*5N,9H:J[P03'V=[^=:SOI MFVKE-HV#J;=R9T-%D6W'5AO2YT_NW>?\@I5W)"036NM8&^C!OMN.VE';)_4> MJ360<;_4]LFT&364*([)M^\S,$)?'V\.]"?_7%Y=Z@O_D-S[L`X\D5Y5_9GN]1\ MD%ZV\0V[XI3JZ!R$II6IV\>#TM9R\!:]HZ)IMQ%OJ$YGYN0!N9<7U13'4&N` MY"2Z(6BE(HJF&*;1)X*VFF&;JM8K"UH?C7/,M7"X$T'NG\)IWV6.;!NV*7"B MAE!W+"U3!$715?'45']8VJJ'JFKB/!JN55IFF9*-8=V1 M((!F/_'+1:#AF3^G(?OF&;X)TV>4DE7\_H.P$MB(=*^`V^4]EF&*,>6E\;;5 M3.B:YVQZYIN."\)KY4.ZKIJJUIW>.S^^%[BL&HJJN&H(A(^ M>$NBK73'DHW*ER>ZT&P?0G5'KBIL)Z+M#@/;NFUH^GZBK');R\EZ2;-4I9*` MUI`Y`$HKH9O:QOW>/2%IJPJ.;*K.T:"TO'+%T,25X"98[MP`7]]BBO13%/G) M^JFV?#0HK;3%=E3-;`?E(_58 M`E[W,9.N%\G8ENU4OE!5(=$-0;LJ378JART.1]`ZOS!E6Q$_(=0+A):NPY(= MO3F$^A3C+([Q'L+\[`"DO%YZ']V0&$^P?XABYH\2\,;1;T#`5TS25YB"*3\44'P;`:TL] M=H8ZR-*.OGW;0;6A/!*O,]Q#NA^DN[5H%U+E)9'NU;5=2.471KI;(X_#TU\) MOA5%_+-'J(>FY"K#\Y'7DXW+]MDP?5P.4'Q87G%T6RQ66P$YQBQV:/3V64"( ML13K:YG%;FW?.@L;"F3#_FIDT?8H$#8Z!2^#@HLGNEX6HMSDHX^6IAKBYN%+<[%!E:$XH3( MWT$IWJNY(/Q_>SF0HUK*__=VM;T)PD#X%YFU%"@L^^+FENR+(V[[`6ZRQ<2H M0;/,?[]KH5JK0`^.?3'Q`]QS+WVC=\]Q82?D8!!0HT+^\+Y3Q4M/)3G<^GNL&#TQ%6+-MQQIRKD5T/[2:7&C#Y&1"'F8 M4@#/*H)GA>2YXC#1+)(]J>';R@`ZR<7;R>$]:Y7J!].TUE;E7!1Q*`7,JZP- MIBV5!B=!.<SOF]A=."QMK;L?:W6'7^.EXPTX;W0(.!2QI7_VOB*<%CK^18%$4"`K@ M[G;,?NBR07S7^P<6"BG.*^B:I9+`Q)M59:'U0#FI6B-7'_*'/"\X#+M>DLG@ MHJ=CH5+\^\*]=(?3NT?E@EZ4CI.8.^'!V0U@-RC#*82.=`AT&0RO3Z8Z52X7 MQMU5@J0I?:*;8$81Z,/B)H5\H`RG$'X#DW"6#*^/HV%>K`GUEB=V`5>F&[6IFO,:]E28_=V:J9GFM<]:@)\ MFB%0SZS;"=,_J(AV53U9+XF*XY*N21^\7KZ.GTY,<8PA<2)REPP3>XSX"J<$ MC1\K*6R8T_Z@)_FV@!?/JT:L]FMHUFO!A+2W&[7B>B+#AS`8,.R$3/$.F>6X MB7GMH1,A%H\=NG5;'$"YN_G]*%;+6_4+?_\`4$L#!!0````(`,F%8D&<5#`H M#PH``&=R```5`!P`87!N="TR,#$R,#DS,%]C86PN>&UL550)``,9,910&3&4 M4'5X"P`!!"4.```$.0$``.U=6V_CMA)^+W#^@^JB0/O@^V;;I)M3>',I`F23 M(,X6YVW!2+1-K$QZ2=E)^NL[E"59DD6*/#SX<=VV[LD.`Q.O'/FMZ_HA/WAW:`Y/O'^PA1S%#'^A_;> M&9LO0AQA^&)]XQ-OV!EBK]TV8/LWI@'CG^^O,K:S*%J<=+M/3T\=RE;HB?&O MHN,S,W9CMN0^SGBAQ8(BRK[T>]]^'ISWCH>]_@#^F!"*PL[S!'0Y1Q&T&\#U M;K_?[0T>^D_Z]M_Y9DW\("?UZ(O][1`)[``X5)\^" MG+9R6CX-.XQ/NX->K]_]WZ?KL3_#<]0F5(+DXU9*);E4T?6/CX^[\;=ITZV6 MSX\\3.\Q[*;B9)SA6Z)IGY-$D!,1BW?-?!3%/E9[&T_90GYJI\W:\E*[/V@/ M^YUG$;12X\<6Y"S$]WCBR=_@*]E=$WS!/>9=^5T7\%G.,8U&-+B@$8E>)%A\ M'LL*\L?,9AQ/3EMH0:.VQ%UZA;SC3R:TT,"A:2`%PO M^(A":=OQ#.-(U$E82[@7\0J<[Q`'D\QP1'P4ULE73[EW^\D`Q!(U<3NY7<@, M!6@U,J2>PT$%/D-B=AFRIYWEW6*P)P<0!)C?<2S@-D:QHR'9BTCCY0+(I=8H M3)5N$-J&Y'L1]89%&)S_!3V&&%+)-:/3]@/F\W/\&-7):4*['WM&S/\Z8V$` M/?;%MR4DNUH3*BGV(]`,TD4;W`@'H'_LWK42J4GV%;41U$U0/Q%L$J';C=_" M]=N#3DV+[05SF[!5^37"I>!THV)J*;L[A4,'86&)S M%CJ1H73PEV'L7M?PN4"!GR,8/.`@Y2-%?UUE")@EQ(FTJ;\C\@HRAK.X9+V*($2/.(QO M^V5T=_-0:M.U)ZW,)^P6>VQU5)BZY8SI/<3<`K4OH)9W.EK1.[LL9JY`&!^[>\ M)TRFLP@DMPH@%*0+1(*+YP6F0F;]6QB1\+72"MST)&9P#:S!9:*P.JQ+(K@O9=ZM]7T_B1&JJSDGUFCH'3WU'L4._<.#\4V7\[R'_7Q/T M2$(2P=!97QE6-72@WTH&E355K:*QY32JMGU5]U6MJ7,.!6.?%60<(KO9W*A? M#U`=D>7\:@:4F>;N`886)$+A-48"WSZ&9+J>A:\!K(;(`/7Z.H?0.9Y@D#"XQRM,E;,46ZW,T#BRBX9"-^5[:TG)\U2_"L1G)'_>B, MS>>,UH*QW1%7*JUI;SK5FH-3HZAPV M]W+5G.+@`G%*Z%3`0&0YEU;%`53!Q">J6L:$T/+0RPPQ/>+\4R']]F_TO-1MU,]G?Z3;";)AX;.+EV-C,\/$DAFJ&8/.UW=%9Q)$O MUZ]ULTG;S2PGJK)M2X.O2IV/!UQCN@T]N54DP=V MA[G+SN)^39'$Q%;";9?V[B;LO+]GH/R\E;!_M!K.F;)2 MWVV6U'?.]<8X!)[3]>'E$&0?!7-"B8C61Q#TZ)D26RYV&L'8S"#.X5GJ>ZZ9 MJ$TB^9:N!-RV],50*R5^%^='#'6I=\YMY=IV?6RCT"5HO#[8MP0--I,%'S$, M"_"ZW0-ZQN(3H8S'9XHBS+&0FUR+7-9S1I]P-&/PS0J:%,XKEGSW326P:NFU ML/HTO-7*LL5T MW9)KQ0R,V6K+F%(;RZFO4N*BP[X]^J[!FNF69.B/4&M/E,NTRM:6,Y\AU$HU M:_JC-UWY,G]\2K:(=&2^B"2Y>&LV5IV.RTU_YWC]^XIFF5![B,F`SNH>Y@7' M/ED[/8Q5YXQ'Y)_"F?VM_,>O/'#/>)G>\1SSR#T#:-XO@C9"\9CS%?$Q^*! M(RJ0+[5,\^S%9()])>JOYFJ_\FWN#'LRI7L^LFV-[2/PQGU2%:GE9;*=T&YB M%!?KVI+PR<,FTM,X39ZRL2LSRVMR>T*]B>&^`S\HG0Z69B-8/Y-Z=@;F06YZ(;QOVRQKCC;$5@ M@/WQY3/4)GF]H0Q9Z2*Z"8/_3[XUFY%IB$S>*ZOG<\QRRMM//;U"4?.8=2ZA M*A1?3WJ^(O8J&=@\AI<\$?*!C?QO2\*Q\@E!"CV;,'`S:C68%@[S-;;4=^/5 MV<3'KEY=R<#J!K%%@M;M1#Y3-GYJ8N5Q;.5N,7,&;GJU!M/B!I>FEG+/JT%U M'^,@7J&Z$F(IC\?<3M)3W/D'=F\_Q*V6T,T.V!!=<\LX5_Q6BYX[Q]L(TP*= MYRE)MM#_7C[>G0@_9&+),7SH=[R84"[M%TD/= M=+P\D\V6A+=Y2KW1:TLRZ7\O2S_L>#$'+V$1/V4_8^(52Z*]&U]]LCN3^+@L M\3NP=X[.*Q_+W[N0FE>=I%+V>V4ICT#*#:&WH3S@:>V*EZ!D`O;+`K[O>"42 M2R'6_.4FF5*#G6+1N-TOR8T/>,9^I_>B9/H/=XCF3"LO8WQ`_1J\/"73ZIU9 MQ+^Q(@W>J9)IG8]M/34Y.R1_S$^(-H>LS,W"V; MKZQRW';<%%\.`XK`Y&X(O72Q!K@7W;=>UG=:=>]B! M?XYK.)[$0K&2+U%](J'35.!V4#E=$RH/*7^.96!_*EXY>,(*^"/ MC(TX&9XT\(1*2Z6(2B`UXAL37?ES`K-+!&IR-)"]'<@S1@4+`Q^RU/\;ARJV MMR-"I"A#6*I8";PERS>80TA&1`8>#LOPE6M6'C\U5XEB35P/KR=J,0.V-@ID ML85:`9]A,;H(V=/6>-<,5)0`(@#C-YP(&,9H[A2H5`+I=CH!=>4U#A.G-YC: MANJ50+UBDD#R_\2#D,!2/4/IGB\:XP5VOV(WG.Y-+9JFFR;0K=W$)=DW%CQ.8FBB!C[B6H M\X2SE9E+MJOKR,((V`A/EU[!XBCD:PQ&0\(WQ#NLFK]6'$8;H8P4J@?%V7R=%-HB8TAW%8FH-%WD842 MC>PEICZ:JZ,E_9I`E_=[*>(6P$P[`[C.JJ)8%R7*-<$U:/]2O.T5O,L0T=LE M]7<[B7!)(YA"/R@*]<((8D.4-;-C#]9;P]2!0W,'E!44FZDM:_2M8PKY2,W" M0'@A$U-.X(/;1)&B`KFL6A-,TQ8RA?Q^%7*KB;)&%K'=R5IBU%JFX#^L@F\W M460!Q2:BI3`U@N96Z@J]OO5,`1^O`CZ`:&?T4*)8%\:"9C0!Z3JK(`\!Y$(1 M+33K6RQRNM04G[N*[ZB)5E1>9G9MWGRF/K6VFH;&O;HK9J6U/WVUM, MY-0IE!I^E[R/3]P+F;?D4Z@.!!C/+2.C\F^(Q2"J`:?"NL=X8D?',R24(KD3 M-9"6X\8G`&_BV_UT1X)`DAY$#":.S^ZX[U20A\4\:DD]SG-TA.2K/>U0`CJ@KF`6ZI,H3K)2DW+<)A:0L MAYL58]61TG+V*/[JW+4;OY8P8"$K7BD7ZR])\H@H"+.6C'4/?U5*^FZ.&U6Q MDKPEV&91>QYMD5LZYMK;,K?^XE1AZ$/1]4BX#&">J\T:!)PO\9NP7"ZT\OW* MN5A^+U<>YYS$9X;`M?M)M<&^'@X##UH$**ZZ`2<>Z(G":.L5:LC]:N-=`ET; M\8I#?DM@YOKJOF*],-AYHOVC/0^S%K0NP$?;!KB.I;\'BRHG0GZ%>B,J.OP; MJ%!4%W2O*V/-#?2/7X`[LWIV0R=T7.[3+OX%RRE7QX6`WXBZK,*KH6H-=-4[ M1QW49+:^^:6J<&XX+,^N$5,%^J^&N#(?M)5RM=N1*:C6,XEI_0+$M`J):>_1 M!+O`'CD=L^FB'RBD;2'^:EA:@:PCY6"/2/E&\9A!8OU'?/5:TIB='+U70Y,. MNXZOPQ=^;8Y^?[I6T(7C0'LF<.&DJS(GO,T!I,7<#?[]$BV:,>)UB04\_CD%I))V+8 M>^7J[C%%YOAUW'W8QP4S.M@5%:^8AD;WF.T*'-.EP7'F#-9><1DP/>SJVPGE MI[('9M]6R#V(W>$W&,H=.33\1H/>DY@I]4O]-S"X\S]02P,$%`````@`R85B M03N(0`*''@``HHX!`!4`'`!A<&YT+3(P,3(P.3,P7VQA8BYX;6Q55`D``QDQ ME%`9,910=7@+``$$)0X```0Y`0``W5W[<^-&ZOSSP`$(]Y@90&O7'=V;MD]_#K MF6]Z>EX]/_[M<96@!TRSF*0_'9PG=3P>?;D>3V]/I]`!E>9!& M04)2_--!2@[^]M=__B?$_OGQ7T8C=!'C)'J/SD@XFJ9+\@.Z"E;X/?H9IY@& M.:$_H%^#9,,_(1=Q@BDZ):MU@G/,OI`__!Z]/7J+T6CD4.RO.(T(_70SK8J] MS_/U^^/C+U^^'*7D(?A"Z!_944C MCD_>L#\LXS1(CAZ7S):S(&=R;]CGQRJ_YC$Z1_O^;\60881:YPT>_^8Q3\=U*S\\O:(T+OC-^/QR?%_?[R\ M#>_Q*AC%*6^D$!^46KP4E=[)NW?OCL6WI6A'\G%!D_(WWAZ7<*J2V;>Q0;Z& M)(O?9P+>)0F#7'#,^C-(*\'_-BK%1ORCTXJ4:3$+I,=<_3O$=:^R(_]`[_D,GW_$?^DOQ\66P MP,D!XI*,C5J[WC7**I2.?8.=81J3Z#S=#75;>R#XK._0?`\#ZOK>39B3/$AV M`E_7]`[["N]6XUL]_S7-!A6\6TW7-)NP$_[A)?M3`SA^S-EHA*,2.B_+X.#$ M3PF_6Y1=E4["1KD)=Y:$-FLD6*?YB(\[?%02]DYF5_//U\ME'#+_+54 M0$P#52H_'F]+WH4;!7J!?!ED"P%_DXWN@F!]+&(5G.19^8E@T6A\4HR-*[G%K.XC_OD5R;'>B:CEO+D/$\S*<:B$!F]^&[)VZTM1,=E`7/B%VOV4 MI&P&F,>+!/-?80)C?>,;A+TQP`JXHH%6$@87;/#:A*C)"T)P:HQ?B!5LYBJ] M4\HB_SS.G_@TEJ[$+&ZR8!XI"'.536YZWKC2QXR*-BY*,!C4`VEG;"E412@B ME5%-^SECD@R'1W?DX3C"L0Q'V!_:40C[Z+-$<8/O8HX\S?F:2X4 M=K6^]\4&):R2!8TO0;2^"E&[U2L9Q(6&:.O3#:4<8YR%0?)W'%"],]"+^F*` M#6Q)!IT<"%Y8P'5FJ5(<27G$%09U#C)8^0TGR2\I^9+>XB`C*8ZF6;;IK'$X MR/L-)RVPFV&E1A@$B5P0MIDTSD0DT`$!&Z MJ#0TD()(2`XXQI#5BJ2W.0G_N+T/6'5<;W)Q8I/Y+KU;-"IY'F\<#&B-.@8- M0$1R@*E;6A6:2*@>(JF,:MI#KL')B9U<]KE@GZG"&8.L[[4X+=SV>EQ'$`23 M;.BTZW+%_+M8GA,JP[.&KP:X<:8F.0QC.E#5?*G$`+*EC<@YR3*<9Q8:MH5\$DX-L$ZMI@08$BEA=78B;F_/Y[>0 MJ%"L#S@QHB/KGQ@:N%U^M`2!T42-3K*M7Y,+>O5CYG@-OR82A`,H4SH.J->(8MH)8Q&*,4B M:`J2A'SA5R_1DE`4D;ABWB"BM(8LPH66.:/\T87G&(GHW(:SX'U8][9A6_SL@.ONF, M]/*`G)$59-<9217AA'`I?\A'11@LLX]P@PUHEO$+XG!E'YV$!"@_8VS\(=I= MW^0#M+;C(&,<72"U]F4<+.(DSF/,;X:+/;Q[DD289MR;Y4^6%2)W=9^,Z6M4 MG5.NNF!\3$_`;4I>3B&2+Y^BYO)5A'("F>Y7#$+GOA2 MA64&IA$>8DE)#5BUIM24!$,B(SSMJM):2L,@3^MZO!N);$I>%\2=#&BLA!LU MP)#+":8I>T'*M8"Q+5C'/`S%08:O%TE\)Z[!6Q:-;$I^MU]<#&CNNY@TX+#- M!69G#K@51)LTX@N3LAB4\')@<([Y7;K!47?`USMUG;SG0=(,NS5.JH7!\,N& M4#%:9FC7XN93!G8FUO4J9U?2W!D!YU`T(^\5:\==PJ*Z'H#(J&N&0W"T M50+CF%R1]@R1#E%"TKM1CND*"!NW$XA+AFS.@-5G'_:YBEIKH!FAR03-E%"E M`H>%3CB=)X7@V%?SZ7:O/]B@:1DMP0Z3QO$1WKA(5JLX7XES?VG$.,RO">,T MU'/#J.'7`UFA-[V/5AR0Y[%A['J=2D.>QJSKP*!8[UU#*/N$_78&OX*]P-Z[ M?W6%;\2!E/P)O8KP,@[C_#60G9D9+2:J`JWII+E2TO.A2QW4UEG+MA@8#NFQ M*4Y6%@L(F;S[^Z\G1^,QBXHH>N!JA^C-X7@\YO]'F;P6'&SR>T+C?^#H!W1% MRD]CGAPGD@\'[C9W$OVGC'H2/F>Z14@6P/CW49,(33`%,-A"2MJ,:8 MEM2I=O+=6$\V]O7)N\-OQ]^RK_]#\.SDY/O#=R??'G[W[GLS"U&0HUM6_2+9 M-7H[/I1)SKG4&0Z+3T_$I^S?K)PU#O/X`2?/FFICCW7[*!)W$H-D%L31-"UF MX+KU99VTUS5[,^3&BKU:%`RWS?@ZJ_65-.)'UD=Q6BYSP.#2#4!3 MUC6R21AN5IN$/TAS)D,&336X*/IDF+LA=;+9M<#PSAFJ8L.H%$1%&`B#>]W0 MUCD&'GI2X3:9@+7>H<6G7O;(C/,(&`RR'92TK_QHU"`=;;4LJBEU8#'/$:UU M^4V$:%\#+YL3KEE`KZG(+Q&):'B&J4BIY#1;TRL/-PFV&:2?%^LTP8RRO>!: M9L_;N0Q$5LJL7I-J0N54(5VEX5BH,T#/OK8&4-9I8-K8UIDBPV6=2)WG!)I0R^,+7E1;."9N& M\@?0+P@5*:0R-LSR_(;BC@S?]=>&W,_\&WY]U@M43]/A/>,/@.D6+V&5XG*, M*(*?@!,_!J-#7<:A2/II=KD=*;\[^DJ(S0W\A@@88JEQ=3),22FTQ,6F/"5/ M00+GALQMD%0F_$Q(E.D3:JI%O9XN,H!MG"]2R('AC0&<(F%FM&%N)>,J,/@B M/./U&M.`7\21LQ&-H6I1[TDS-6`[V3-;: M[L$Z#]9"I3[W14'-]-0!5Y&TO%>05ND,'V:WX-O#YD(!C!=Q0=E=09`Z(FZ) MMEHP>':+$U;FW<\X9:XQ879-HE6@R<;[$8$I1.& M-9S:8'8"JE(>A5Q!)JZ'22X9&%Z2S$JKNN0@A.I"55)I*P:41!V`FLV:5USD M->*U@8A4)BD4_O`I@\19ZPZ6S1N;DOV)BF.68U99D/=*3\[BTK(3;WE!LB?CCS3G(FQ7?\.)[)0ZGA=;V3E"I' M-%@$*9^W,BXQZ82'H(L:L(HU34DP#L<(3TL>Z6N@<*<"V/10OP^ROE/0W(#K"Z*\>\#3O%2 MFYY!*^V_>VDA=[M"1Q30,&+"I]CB>H@S_FP\?PH5$(FN<&Z=4K=D?!)&":]. MDX8`+)^F@M;F!9-!"?L:!AG*3"+E]94(;C9`H0::YDF7`H.%O.+Z[9V@F#VSTO<-7 M&YZ`ZWK9.8QN6;[I7XQ/HNYJ9)VY?Y71:#`ED.V*L'KO:*#KEG MG15E0.1RP[Q=B"P*^.I87$?=IK#X#C1)BZ'!]7)6[U(`$-5FH@-5=45`)ZL% M=^7!T,R!Y#=[-3E%2^R M1%P)"2W'"U]PIIYOP#2"&A?LF>8-T^/J4X6B:5KO4$YZ15V:4,[N`E_DIO[ES7ZZRFHEWG_]WP/22%S2NF_*W^BF4 M$T3+'^/;U:(/\D_YGT/N_C;L5U"V&VZ'VGT;<*LASQ?6=&!ME]>MN5Y>Q&G` M>M#V?-M9G,D7HW6=W5G=JQ_O:53#-SOJ0F-I3]P=5UIG*`L8HT(>L;]&>`'D M]$^Y/(LCR%YA'!/9+`7'#X:W1=U4AV6YWA@SE;MZ@/FJ!:MXBD,(\DEA M(7F(&(LCL(YZ1C%_MZ9\5[PX_5(>II1=T[F>W`H;EK!]##93V*4DP*3N`5^1 MP)>K5I>*Y`-1[6:'U[<43TG*)16K#>T.X[-;%5?P9IC$_-MNL#^W2DY.NWW6^'N8T5_P< M%+UZZ0=,%R3#YK4_=]#=5<`BMWJ17P$&'15S@&;X[SYW:.L-/,M3FV&9QS65 M8)US=86KSNH1;#='8#"/S20=MWWT^Z_.!7@^2]W3L-9NMZ/V$(/ZW.$P=C_X MJOURZ_X<:`;+.S!]MLIW*0@`HQT,=6"VH10PD[2=H7<6QSBSE^+@C;@#%9F,!8$@,H.ACI0VE`*])C"#MT64RS+$N#%%#=X70Q"U\LS MO."#SFFPCGG_YS/:ZT42W\E[X)I*ZU.`WS2/?0UKYGQTU8864_1&WDT*613` M8XI0JJ*$ZP)QR*Q_AAA'(M,!?P"*=2U\O;PDZ=TW2U9#F M@YK4NBD"+ M)V44"H.^W%@1IV3W?,7C(4AX_-)K([9?$5[?G-K!N,9[5#WT8=%X!^0J(L>% M*'H5%<*O^8J!X#=?ZA)_P-L?&.C6I-K:">O)E#ZQ7B>>5W9OX):BYUN6:]%( MMWE`\_XMK(.NG":K6O`0+?!=G*8B$=D223#_/YOU[0#->IX:9Y#]@/=H5,R/ MOKDTI\?;5?*D$K-J1I(X=+A#:U#P>H/*"KQQ9THK#294MT+4'#+C/J+4`/=6 MZH=-%JIO7)D4A.)G;TZGHP"'V[6:\3D;0B2*IK6?(#:P(2)U6O-_5Z M&-.XCN>@!X:8/T0U$47#%E[`FX3]LT1TG!VFO*'7P$Y4K[XO;7,XCIUPGZ/E9L`-\^1JR3! M<,P(KWM$?)&CK30XE]0UU;$28".S<4,"#&&4L#IYBX40.%'OM]LA#W-:J8F=%0&P\"^B-OD_'<68M6*0+(,&`S=6B'V>*L, M(#Y;A=6%I%_,: MJTM]"@!#Y%U0=_8XMV6(25RC%,C+!4[&6]=)>Q8"CM3F-=->)7Q=M+:YX^^. MFE3>E[3!.LT%%SJ_EGL0HR)\5QMB"I$J'K8G%G+1]4ZVD"YY:C MRN!DZH>SAE2.1DGK<')TQNJ M-<%46&IS?A&>_Y65(`_NP_`\FCM8TS3<\!1$VOU0BY;?G6@G$YH;T$:5P8G8 M#V?7L=4NQ_'`YKIDJ$T),'11PM(_[_.[$`,R M!:Q@7<8IGK(_:I.N*P0'84<'J)(AE10\EK2A&9C"19&0!4(7OBL]35GP&^CR'T,ZQ],L%-&PP=>T-6TC2J`GA$V5\A MDO1CD&]HG#^=,7Q.==%4&(Z$*N!ZTM6E@9),`;%-JE($14#95,Q+XFJ*PM^R MG]$XQ"=.=6#4'XYK#F;IJ6=0!LI$.^+N&G\IAM9<`N:+W#V\H.SC1'@&UN<0'^RMT&2D;`)OY/:?$"'ZX>0G.R6ZDW M'*<,9NC)I5`"RC(]4N6Y^?*).AB$$^O)/`D,`\]"SO1.)B(0MYFWGI>?;JG\ M]BT.>7"J3YNR9YG>S[GN:W[G[.NN!8(A^'-8H7BJD3_,6.U)P."_V)XM-ELT ME=$4\9KG1P&ND#I*958HG7LK5(<>E M)(WND,MY1G-,*WE*13"4ZX-6L6DJ'N!YKAWX%QV6Q;'0[)G'9>="`0S,/2O` M861V+!$,UY_%C,XBMM"&-C8;3;UA?97&(0,KQ"9?`AI=X?QZ>4'H$LX%+HU]$A>EC2S?A;JM9274+I&BV[1&`N+98U(6RF?HGS'RAPRJM6%W:,2?GI:-6'9.PZW@[FN(*OSJ18E,8 MG%9]4#JN`_`K?=!&WBK30#T7@:Z':82].C$CX(;G4DH.SBLG>,K%UB+O25@3 M'RB5NWR3^Y1?Z5&?RV@(>,ZX;ZIT-:[._HZ0.D2%W*"5K*]=<-5JJ<^!JO$R M#A9Q(G8R#(3M2@&J7@.X=E771(?F;PV*I<9A5K5+'0]4M=W<<]K0O2$%J*(- MX)0!>B'Z39$G#TUR%F$M-KDX#\+BJED`@^J3-')K'9L.H+9RAFKH*2*]CSW' MX8MN"3W@=*-V1N5W@"J]`ZD[R9`"Z/0G&ZXXO6+W7:TP#GO%& M9##C3ZX_\C!57=]:84`-8,?8;I%*0Z8KE)0OE(9NE6G*Y@WXDF3F]MB*06P) M!3I]&TAA](J+OQZH^LN#9`4+5%7?$@%4[3ID[2HOY4JN#U;7)3GX(Z4R_=:& M$:%@!$FS#WA)*)9R\^`19Q_CE/`[DZ4%K),W2Y$#UD>[RK];1Y4.S6R!HBP0M!)0R@I0_@&J_<%CZ#('SD/$YIP&A49P& M]$DF$SA$5XR)K'16,XGT,O8SH"](^C.\ICB,@^*9I(F\5:)=$S.(`R*5"\KN M/9FMSB%B?TNP2"#,Q^!Z`:(!UY1$&VN"F9=T-67`2I"N";,E41M4BK*F6H27FUH/LS(1&WBS&M7.Z_Q?0A#G$VW^8V MJMZ06BYQJ&[J/8L$Q(#GLL2T,"Y*%E2HE8W*PE&M],/Z(USR%X8+6AJO]T[3 M5C8W[O_D=0/+>MIN)0&BR)X&***"XK'CL_ICQU7"N_K;,>6%CN%7]MA4'O-$ M:<7DWOUQ:R=%0*W=#V]WM)?:J%`_1+(`I&AU,#V[FIKJ=W:L2H!:T!VK8]?< M3MT'W3"ZPCD?'6:4/,01CCX\?="Z87=M0$VY`VC5^_)B4"T+ MX:<-7_%R6-.^KK=M5=9`[5L]J4`F(9L)4LP0,W3YTXP9Q&>C?'ZX7FDV"MVU M`;7O#J#;[5N]MI(35!2"RE*8]^7E'%9K_*(H6-U73O-W[;X*;4#-NP/HGMVW M*FKX[GN#UP45KY?\$B]/TJ]..JO>Z''5!M2^.X#N;A:51?#ILT@J(M[;*!+O MBG)0K2!8G;>:[N_4>17:@!IW!]`].^]VL63PSLM1"O9F]WR<>`@23DGW64X? M?4!MO!-L9?9_V6G9'VKE`)K\O'C"_8B$WEJ4_99(#J$Z$ML;<_*(@JKD:PXVXU#"@71J:)2!:V$SA"-\OSW ME$`UD"/:=C/1/>\KO51KW6(F$?&K2]P]:#J/2@A6JQ@0MELB$Z*(RR+NV0;L M*K4@B,-FD,::%M!*PFH&&TQU%FD9PXFV*'I%G/+V&2O:I/[1)?L3^[C\B/V+ M[U*S3_X/4$L#!!0````(`,F%8D$T1,^T<1(``&0#`0`5`!P`87!N="TR,#$R M,#DS,%]P&UL550)``,9,910&3&44'5X"P`!!"4.```$.0$``.U=;7/; M-A+^?C/W'WCNW$SO@RS+3MK:3:ZC^*7CJ6-[;*>]^Y2A*$C&E2)4D/)+?WT7 MX(LID2`6%&5`N60ZC2-CH=U]L,!B@5V\^^EI%GH/A,>41>]W!KM[.QZ)`C:F MT?3]SJ?;WO#V^/Q\QXL3/QK[(8O(^YV([?ST[[__S8,_[_[1ZWEGE(3C(^^$ M!;WS:,)^]"[]&3GR?B81X7["^(_>KWZX$)^P,QH2[AVSV3PD"8%?I%]\Y!WL M'A"OUT-T^RN)QHQ_NCDONKU/DOE1O__X^+@;L0?_D?'?X]V`X;J[90L>D*(O M?SZ/_(A]'NS]\<_]D[W#@[W!/OPPH9$?[CY-0)83/X%V^_!Y?S#H[^W?#=X> MP7][`^3W)7ZRB(OOVWOZ82_]DY*_"VGT^Y'XW\B/B0?@1/'14TS?[Y2D?#S8 M97S:W]_;&_3_\_'B-K@G,[]'(P%20'9R*M%+'=W@\/"P+W^;-ZVT?!KQ,/^. M@W[.3M$S_)8VM"]Q$M.C6+)WP0(_D6-,^S6>LH7X5R]OUA,?]0;[O8/![E,\ MWLF5+S7(64ANR,03?\-8*;XUPQ>&QZPO?M<'?!8S$B7#:'P:)31Y%F#QF>05 M^)>=W7,R>;_CSZ.D)W`7HT)\XS<8VN1Y#B834S'B=[Q^.R:/612SD(YAZ(T_ M^*'0[>T](4FLXU!+V`E[2SU?^QQ4?Z$P9(!&KQU>1J+F8H M0,M(D6(S5)5U:;@-\$_A,E&`NM-GZ- MH=_;W]6T."&)3T.].CO^GHT;4_9]ESX7<_8#6<>X5'UMR-A,6%_/-82/11?@OX/_[^44Y1]AW^2EY%Z9 M/F,Z9SMDP1*GH7"7&=?>YB<_A*$ZX'Q1K0>B/2"B[_RQH<:3]-LQF M6I4.?$R"W2E[Z(\)[GM#3+W_1OXZ'/*PPV94O'542*V3`K.ZYNN M#4,>>(R#00!<>:<^#Y;&0'7+D;7HSZ5SV@ON:5@,GPEG,U-=9GIC.DG* M^@4>7AV$8Y"$^^$YF,O3+^2Y$85*6R0,`P=Q4,AM`XA= M4GN=E#:U?4TX92#"6`1Z-&I?:8O4_X&3^J^5VP800^!F+#@Z"_VI`H"5-DC% MOW%*\;5RVE#X\8(+&<]H'/CA?XG/FP>_NCD2AK=.P:"3WMX2_!L)PU\B]AC= M$C]F$1F?Q_&"\,:E6$F#Q.8[I[!!Z<$>0+^R<`$JY,_R6"-N!*;2%@G(]PX" MHI#;HK.:VO`-F3,N@BKI(4NSSZH@0<+R@X.P-&O!'CIRE!S#E#IEO'DCL=(2 MB<6A@UC4RFP/@NO%**3!6@_FL$MC@]L=F,13(D)Z-<\=4B MD0?J8*3-DU0C(18?)[?9")78W`6F[F"Z)SJ#SU2+24-[+#QN;L>5"K"/BG#2 M\9B46F,1<7.#KA"^!H]W_8IX%_#!IN+D^DL&19!\W^MYQ7$T_%PF]3):+R-> M=W!-_'@D<5K$O:GOS],11L(DSC]9'6K9QY\+#J\F9Q1D#2A8`HLI(J".(UW; M<-K+-HQC4*Y&BM5&-L/J)F`LA5=J!>UR]EH7A,Q?1V%1:6LUQ+X>)@JYW8!& M'%/##"W^$N>F#WX(K,;#Y-CG_!F<$WEO3Q49P]%:#=,W0\",A7$)NV$0L`4P M>4,"`@R/0G))E&95W]9J"!^-3:.@;F!QS9.,)2SQ0]G2 MLCFQ.>')\S6XR'('`5/R7*S`ZAFNF<3J>4!;_P&C!3>L2S_;M9G<-G,8T!8- MQZ>VQCG- MKG3]O!D<'9'=HP@SD'`*<`0L?T[%2DK\F%R-0CI-4\$T8&F([)Y2&(*%4H`; M8('U\P4X2!4!U3.>JCT6HLT$(XPGO6:QW4#G)/-?;\@#B901UDHK+!*;B4F8 M(:$0T0W]H\UB'7MP*YJ`,HFMW%@IIN5+%@5MEJ8R'19JMT(5:(6X88PE'T@D M'8JWUO74'G2V/?_'PNA6KP*JC M4]A?.64`4?>OR!DX6,D96$X3\+Y=(O_7U[2!5W#C0>577/(\EC[6->$RBPOE MV:N)MS'-P$PQ;JR9RSRG^7?#17+/./WSQ8(;0:P2;65"`DX3[J(F*R&8()83 M6,U!Z!*M90VXBY0^Y5=+934WH4O,-ISKVTF`Q'")0U%:36%8)RB,U(ES("*7 MMD8*JTD/'8#F]J)68;1Q15.VWLIL!HWLC@*D7\@ZJ5KAUIZ\9;D*BXGXFB+U MQ>[Z35-&_DLG'IMXI6[LC\WH"W@0:24GP!_(9-Y>T/._6@J MAU3._AT#MU(41CEC7&:8Q>*Y(!+%4M/B6$+I'G3\'5;WR!C$-Z)3-X;+!0U$ M`K7&2BNMK&Z1,9`IY')#Z;=^6'#V,V/C6)U<7-_4Z@87H_XF"=W`0)IGYFE% MTW3956!0W]3J?A6#09.$;F"02Z'QS"QO.W$KQ+(DVWY47+_B9=4VC+R"@L;J M?M3(K4:([H;]W)(0^IRF#T"&P/!P/*.1?-Y"/./2#!>6V&K^O@%N9LIP`\!B M=CYFL;P+G'&IK&6A;F\U]=X`)JW(VSYUKJRX%RS6HEEN:3<5OPV053FW'D+A M.:5BE0:H)HZD([*;P&\"+$IZ-R;0\R@AH$>-9U)I93=/WP`+A7SF!G:8&EA$ MIB+@;-_$X9_.8!FBP]!EI[B/!*'-@M+6`T=EX= MEVU?OPM59-/F!]@33)29!&`\1I;QNS"^7)-%ZQ"MM[)8[,`"@5K9M MMZ(\,R6_?21>$@]$5(2&BT1Y-J2ELEO8P`!4I/QN6-=OA$[O@:OA`ZP*4W*Y MF(T(OYI4+E%H-C'FW=BM=6``9UL-;1>^Z!@?Q^>/\4$ M=JU%_'D8)/0A3>/4O/"RD:]R)1\+-1`VJ6TWQM,)`0`"FJH_&@]GXHW./^4_ M%<.BD<*5_"T4N@C9MS]R7):JN%W^";DE_($&)+[C?A2#RD`KN1I/)Q,2*(?'VKVZDGN& M&C4=Z7#[!Q,L?US4K#PAZ=^PX"W=GLL>N8O*Y7UAU=1G1:S7JRLY<:C!U)$. MW7`CJL)4WP)#HUY'ZDHF74MHU=IP%;_LQ;"\.+3)@VEM.W,E!:\EQB8:5HMPXHFA=>10)N84T MT$?K$\X'PDW2N?,FTIMG;=Z16S[J39XG,CXECH,C.[` M[IW/%E%B0]6L.__?.3TFTIM1)A'F-AW9O8O:T1A!J,H-#Q&\FBSZ/0S^6%!. ME$^=*B`VZ<#N_513:,U5L_WN'WXXKVWQMJ^<;L[2OW#7H`BFK[L,-'9D][)I M1X,#H2HWEH$;,L]FNZO)"1F)V4WQ=)$"8I,.G'FU"P6MN6JV?QF`<1P0,I9W MXT5Q,%'W^&J2OX(DM*#R!A"$SKSDA?,"T*IPPY+K^2W5$3-";HG.F6>\U@"N M1A%NX(9?0=9>9&U?9=W%Y"7+G.Q/=BD_'@AV+],0K&FG7AS+MAJ`'1 M1CU?YI`8@F5P_@Q&T/BP$H[6F0?)UA@$"H6T1G\N!Q7PQI/_@S'P>=_^RV<; M&`5"K$[&P6FTZIR_^OLE,85]R'6IQT*TXN+\=U[/$Q?<0A8O.(%_#'8]22BN MRB^16KRUF)ZJ`D+7+*0!XK)R`X%%D_RPB&E$XOB$Q`&G\^RF:0U,=P#TAU#M M?[?IR.:5>SV`93-MKR;[J2NWB_D\E'.2'^9STGDDJEHJ[._[5?O;W_7*G;RD MJWCE?BQ>':V1\#3]0)O!@B*UO&8*ILJ,OH`3Z\P23VXU_\4`P-75TT0Y]HVQ M_`*WN#K)HFFO$H@I+/&'54L\V/5D#U[6A>='8Z_HQ).]V+Q\,TI>V-58GJJQ MUIMVTN;=4(TB'+`8D?[1D_D?^>%_Q60&>ZLF\Q9, MYH70*R@MSL,%>S+@7116A_#N-!#/Z]PX,].?0%B)_E#O:.%0^)O=1"T=W#0A`Z4`/U MVJ>J:FK+36S:(AZ$NL*G91'7O7^@&"4K>4M@[`^$RSOF^LL@2%JKI3[:`6"D M%3=NABANFYU'P4(<7RD#EQHJJY4\VH&'U(3]]:HI2IFM")<^3Q]BJ*Y)!RVB MEL5*XQ4=?UUS3(IVW35DL*\VTIE.91BZ8D"K@I1S[EP``P9A9R.*#3U2E_+J&6Z'\.L;+%]J<4?ZE/R,G M;.93=6DN57,'@%`/)#4891'6AD2Q=&4^'H71(69-:+#WD8BZFB9.%8 M?"X`;M1T?=,MTW&]$'EMH-;:W<1DGF_U;V!YDFO4^)KP0.AVJBZ@@>_`B7*K M%7]-/=-CU.'&?GN9[X]^LA!OAYP`RRC8E@GW5CD29Z9E49\WT&7)+F:G#$^(301.4)MK!+7[_;=[NE,F6Y,URL<2\+UI'9VZ@WCB(Y2^O9/YN?/I$>$!CY0VD-AUMX:6D]OIR M&N]TY*X/=U,_5@-ZG:*MUY;38&-=TH?3^,GAUP*^ M,IW5L&#WQM@I>(I-P.CU(7#NQ"JUF>^FWH M6V36Y]=]Z+JOUY5S!U6SF:+Q%NX8&\4VLI7L-^)_(F<3/OD+4$L#!!0````( M`,F%8D&7FGN#@08```8J```1`!P`87!N="TR,#$R,#DS,"YX@/T'3L"`[D&693=IXL8M M$J?)@J5)&KM=T9>"EFB;"$4J))4X_WZ'NEF^2):]%"WF&D$@D]_Y>&Z\Z?CH M[31@Z(%(107O6FZC:2'"/>%3/NY:'_OV<;]W<6&AMV]^^Q7!Y^AWVT9GE#"_ M@TZ%9U_PD7B-KG!`.NB<<"*Q%O(U^H199%K$&65$HIX(0D8T@8YDI`YJ-]H$ MV78-VD^$^T)^O+W(:2=:AQW'>7Q\;'#Q@!^%O%,-3]2CZXM(>B3GPF'(,1=? MW>;]'ZW3YF&[Z;;@840Y9HWI"&PYQ1IP+6AW7-=IM@;N7@?^FF[-\336D*6]"`HP@\EQUK8(W']L-(<=. MJ]ETG<_O+_LQSDJ`G2FC_&X5W#T\/'3BW@RZA)P.)(UQN+!@0['A-]NNG;;S>"1 MLL<8A[G("*MA3)UVK!:1@A&U4B;N62'$!>=1L-H[OI:.?@J)`R`;4$12+Y=; M+S0O`#J8YM7:Q3TKM#N^N1KD`NE<@JD8Q%`SFV`Y820@7)\)&9R2$8X81.X^ MPHR.*/$MI+$<$VV27878(]5DV83!G`N85["2I"VF+0PI3!QH^.7(9%C'>'0` M>B/S`.O'2FK3Y\"DBXR.Q]Q_QS753V8&RB`>P$+4[UJ5"#,D*!`/ZA-8.FBL M&-S;KS!$LR:$$U!V<3E%?WE/F\O^'S>S>C%',^?N^CV8A;F MGE+7H^O0')I@X!497X(K#\/+JM2?L2$Q0C.^G]&8>;F'U>2,B<]]LL'!:9D)%$NX6R&V@F,%XN,BQ MBS[N1V&8G,,PRY)WZ9"S#E3N^U>+OF\U4)%MEN&[?MZY$IK`KOJ$AXS`8?)2 M\+$](.9H/-1)%"H1Y2$X6`Q!NX%B*I1RQ8?.G`T9NET,0%\+[VXBF$^D>GX$`)0P[Z=\)'/5L6'B)#XD7;W&I@U=TE'K8;2YZ M>`\\/&-`&<4NNAA.$IKR,>$>);.#2J&IW*WNHEOW&VA.=A?]N6;?LUN--8A3 MHC%EJM8N6I^M/(JMK;;;VK@7J08[>4^KVGY3OUQA::Y.#V3]AKTD41[4]A8; M>!XJE(^PDT%;WKQ7AZH&KCQ`+^MM^C]C4GH0*`E*#6!Y5/9J'A3^WV$Q_TQ) MY9:,4%R*Z9@W]EU+45-YL]*VB22CKH5#KNWLE?I7,*TQ#5@&,=05I9@XLHO> M2`?.*+#TEEB62D5`(D(B-1PYG$SYC$!3;<2+=W9DQH$-UGD.DQD>;FHRB!#V M#6V]-/S/:J1GZI>;&;F0L-_(U-YLE&S0H,21C%0L#FO>!7@NVM?]<.#8^"4V-.9(?6P.'W*;-K< MQ@0!+)2/G\'$^)([$&<4[@\>Q6Q6&ULTL`[RAS/OV/-$Q'7VAB#--N(/1$\$ M@>#Q%3*SL"YX`Z.2OF%2D.]:GB0^U?.V`C'33<^0K&>H+.$[(.!,+4RMY M-#_^NX$UD[3RI-U`8*W5R4$FM\[,1.B.KX//8-LM,4GAQ;5@",.%4I&)S#LX MF8HG8E[%)B;5P/T`\3MRDLT.'O\%4$L!`AX#%`````@`R85B05*ZCT];&@`` M^<$``!$`&````````0```*2!`````&%P;G0M,C`Q,C`Y,S`N>&UL550%``,9 M,910=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`R85B09Q4,"@/"@``9W(` M`!4`&````````0```*2!IAH``&%P;G0M,C`Q,C`Y,S!?8V%L+GAM;%54!0`# M&3&44'5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`,F%8D$_"SNTOP8``/`X M```5`!@```````$```"D@00E``!A<&YT+3(P,3(P.3,P7V1E9BYX;6Q55`4` M`QDQE%!U>`L``00E#@``!#D!``!02P$"'@,4````"`#)A6)!.XA``H<>``"B MC@$`%0`8```````!````I($2+```87!N="TR,#$R,#DS,%]L86(N>&UL550% M``,9,910=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`R85B031$S[1Q$@`` M9`,!`!4`&````````0```*2!Z$H``&%P;G0M,C`Q,C`Y,S!?<')E+GAM;%54 M!0`#&3&44'5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`,F%8D&7FGN#@08` M``8J```1`!@```````$```"D@:A=``!A<&YT+3(P,3(P.3,P+GAS9%54!0`# I&3&44'5X"P`!!"4.```$.0$``%!+!08`````!@`&`!H"``!T9``````` ` end XML 18 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "

"+ text.join( "

\n" ) +"

"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "

" + text[p] + "

\n"; } } }else{ formatted = '

' + raw + '

'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'
'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } } XML 19 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
2. Supplemental Cash Flow Information
 9 Months Ended
Sep. 30, 2012
Supplemental Cash Flow Elements [Abstract]  
2. Supplemental Cash Flow Information

Cash paid for interest for the nine months ended September 30, 2012 and 2011, was $18,676 and $3,504, respectively. During the nine months ended September 30, 2012 and 2011, the Company had non-cash transactions related to share based payments described in greater detail in Note 5 and non-cash transactions related to the conversion of notes payable and related accrued interest into common stock that are described in greater detail in Note 3. In addition, $120,000 of accounts payable were converted into common stock in each of 2012 and 2011, respectively. The Company also had capital lease transactions in the nine months ended September 30, 2012 and 2011 in the amounts of $28,567 and $85,369, respectively.
XML 20 R3.htm IDEA: XBRL DOCUMENT v2.4.0.6
Balance Sheets (Parenthetical) (USD $)
Sep. 30, 2012
Dec. 31, 2011
Statement of Financial Position [Abstract]    
Preferred stock par value $ 1.00 $ 1.00
Preferred stock shares authorized 2,000,000 2,000,000
Preferred stock shares issued 0 0
Preferred stock shares outstanding 0 0
Common stock par value $ 0.001 $ 0.001
Common stock shares authorized 160,000,000 160,000,000
Common stock shares issued 119,505,007 118,915,698
Common stock shares outstanding 119,505,007 118,915,698
XML 21 R1.htm IDEA: XBRL DOCUMENT v2.4.0.6
Document and Entity Information
 9 Months Ended
Sep. 30, 2012
Oct. 31, 2012
Document And Entity Information    
Entity Registrant Name Applied Nanotech Holdings, Inc.  
Entity Central Index Key 0000891417  
Document Type 10-Q  
Document Period End Date Sep. 30, 2012  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Is Entity a Well-known Seasoned Issuer? No  
Is Entity a Voluntary Filer? No  
Is Entity's Reporting Status Current? No  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   119,675,372
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2012  
XML 22 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Operations (USD $)
 3 Months Ended 9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Sep. 30, 2011
Revenues        
Government contracts $ 436,729 $ 284,025 $ 1,223,273 $ 2,616,661
Contract research 98,888 242,782 250,242 1,086,381
License fees and royalties 109,000 1,608,103 887,896 1,870,943
Product sales 54,543 23,480 189,031 89,236
Other 6,345 90,629 62,150 185,313
Total revenues 705,505 2,249,019 2,612,592 5,848,534
Research and development 944,119 1,434,599 3,674,390 4,428,239
Selling, general and administrative expenses 875,638 792,070 3,024,070 2,247,766
Operating costs and expenses 1,819,757 2,226,669 6,698,460 6,676,005
Income (Loss) from operations (1,114,252) 22,350 (4,085,868) (827,471)
Interest expense (131,565) (86,238) (319,528) (296,809)
Interest income 8 1,822 1,583 15,298
Loss from continuing operations before taxes (1,245,809) (62,066) (4,403,813) (1,108,982)
Provision for taxes            
Net loss $ (1,245,809) $ (62,066) $ (4,403,813) $ (1,108,982)
Earnings (loss) per share - Basic and Diluted $ (0.01) $ 0.00 $ (0.04) $ (0.01)
Basic 119,381,717 118,853,585 119,194,845 116,155,990
Diluted 119,381,717 118,853,585 119,194,845 116,155,990
XML 23 R12.htm IDEA: XBRL DOCUMENT v2.4.0.6
2. Supplemental Cash Flow Information - 2. Supplemental Cash Flow Information (Details) (USD $)
 9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Notes to Financial Statements    
Cash paid for interest $ 3,504 $ 18,676
Accounts payable converted into common stock 120,000 120,000
Capital lease transaction $ 85,369 $ 28,567
XML 24 R11.htm IDEA: XBRL DOCUMENT v2.4.0.6
6. Contingencies
 9 Months Ended
Sep. 30, 2012
Commitments and Contingencies Disclosure [Abstract]  
6. Contingencies

Litigation

 

The Company is a defendant in minor lawsuits described in greater detail in its 2011 Annual Report on Form 10-K. The Company expects any potential eventual payment to have no material effect on the financial statements.
XML 25 R15.htm IDEA: XBRL DOCUMENT v2.4.0.6
5. Share-Based Payments (Details Narrative) (USD $)
 9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Notes to Financial Statements    
Share-based compensation $ 215,291 $ 564,908
XML 26 R13.htm IDEA: XBRL DOCUMENT v2.4.0.6
3. Notes Payable and Long-Term Debt (Details Narrative) (USD $)
 9 Months Ended 9 Months Ended
Sep. 30, 2011
Sep. 30, 2012
Convertible Note 2010
Dec. 31, 2010
Convertible Note 2010
Dec. 31, 2010
Officers And Directors
Sep. 30, 2012
Second 2012 Note
Stated interest rate     8.00%   8.00%
Maturity date   Dec. 31, 2014     Jan. 31, 2014
Conversion price per share minimum     $ 0.20   $ 0.16
Conversion of stock per share maximum     $ 0.25    
Face amount     $ 2,146,000 $ 216,000 $ 735,000
Debt discount     647,250   208,475
Amount converted 326,000 526,000      
Note payable balance   1,620,000      
Accrued interest $ 31,394        
Shares converted 1,764,144        
XML 27 R14.htm IDEA: XBRL DOCUMENT v2.4.0.6
4. Stockholders Equity (Details Narrative) (USD $)
 9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Notes to Financial Statements    
Restricted stock issued   6,578,948
Restricted stock proceeds   $ 2,500,000
Exercise of options by former employees   200,454
Stock options exercised by former employees   51,751
Stock issued for conversion of accounts payable-shares 494,949 300,752
Stock issued for conversion of accounts payable 120,000 120,000
Restricted stock issued to employees $ 94,360 $ 103,722
XML 28 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Cash Flows (USD $)
 9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Statement of Cash Flows [Abstract]    
Net loss $ (4,403,813) $ (1,108,982)
Depreciation and amortization expense 83,037 50,084
Amortization of discount on debt 274,815 190,089
Stock based compensation expense 215,291 564,908
Accounts receivable, trade 403,915 (174,692)
Prepaid expenses and other assets (545,706) (78,108)
Accounts payable and accrued liabilities 812,381 (134,572)
Deferred revenue (200,000) (314,250)
Total adjustments 1,043,733 103,459
Net cash used in operating activities (3,360,080) (1,005,523)
Purchases of property and equipment (50,398) (70,611)
Net cash used in investing activities (50,398) (70,611)
Repayment of capital leases (36,590) (17,602)
Proceeds from long-term debt 735,700   
Proceeds from stock issuance, net of costs    2,551,751
Net cash provided by financing activities 699,110 2,534,149
Net increase (decrease) in cash and cash equivalents (2,711,368) 1,458,015
Cash and cash equivalents, beginning of period 3,071,783 2,732,570
Cash and cash equivalents, end of period $ 360,415 $ 4,190,585
XML 29 R10.htm IDEA: XBRL DOCUMENT v2.4.0.6
5. Share-Based Payments
 9 Months Ended
Sep. 30, 2012
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
5. Share-Based Payments

We use the fair value method to account for stock based compensation. We recorded $215,291 and $564,908 in compensation expense in the periods ended September 30, 2012 and 2011, respectively, related to options and restricted stock issued under our stock-based incentive compensation plans. This includes expense related to both options issued and committed, as well as unissued restricted stock in the current year, and options issued in prior years for which the requisite service period for those options includes the current year. The fair value of these options was calculated using the Black-Scholes option pricing model. Information related to the assumptions used in this model is set forth in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2011. For options issued in 2012, the same approximate assumptions were used.
XML 30 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.6 Html 15 105 1 false 3 0 false 4 false false R1.htm 0001 - Document - Document and Entity Information Sheet http://appnano.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 0002 - Statement - Consolidated Balance Sheets Sheet http://appnano.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets false false R3.htm 0003 - Statement - Balance Sheets (Parenthetical) Sheet http://appnano.com/role/BalanceSheetsParenthetical Balance Sheets (Parenthetical) false false R4.htm 0004 - Statement - Consolidated Statements of Operations Sheet http://appnano.com/role/ConsolidatedStatementsOfOperations Consolidated Statements of Operations false false R5.htm 0005 - Statement - Consolidated Statements of Cash Flows Sheet http://appnano.com/role/ConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows false false R6.htm 0006 - Disclosure - 1. Basis of Presentation Sheet http://appnano.com/role/BasisOfPresentation 1. Basis of Presentation false false R7.htm 0007 - Disclosure - 2. Supplemental Cash Flow Information Sheet http://appnano.com/role/SupplementalCashFlowInformation 2. Supplemental Cash Flow Information false false R8.htm 0008 - Disclosure - 3. Notes Payable and Long-Term Debt Notes http://appnano.com/role/NotesPayableAndLong-TermDebt 3. Notes Payable and Long-Term Debt false false R9.htm 0009 - Disclosure - 4. Stockholders Equity Sheet http://appnano.com/role/StockholdersEquity 4. Stockholders Equity false false R10.htm 0010 - Disclosure - 5. Share-Based Payments Sheet http://appnano.com/role/Share-BasedPayments 5. Share-Based Payments false false R11.htm 0011 - Disclosure - 6. Contingencies Sheet http://appnano.com/role/Contingencies 6. Contingencies false false R12.htm 0012 - Disclosure - 2. Supplemental Cash Flow Information - 2. Supplemental Cash Flow Information (Details) Sheet http://appnano.com/role/SupplementalCashFlowInformation-2.SupplementalCashFlowInformationDetails 2. Supplemental Cash Flow Information - 2. Supplemental Cash Flow Information (Details) false false R13.htm 0013 - Disclosure - 3. Notes Payable and Long-Term Debt (Details Narrative) Notes http://appnano.com/role/NotesPayableAndLong-TermDebtDetailsNarrative 3. Notes Payable and Long-Term Debt (Details Narrative) false false R14.htm 0014 - Disclosure - 4. Stockholders Equity (Details Narrative) Sheet http://appnano.com/role/StockholdersEquityDetailsNarrative 4. Stockholders Equity (Details Narrative) false false R15.htm 0015 - Disclosure - 5. Share-Based Payments (Details Narrative) Sheet http://appnano.com/role/Share-BasedPaymentsDetailsNarrative 5. Share-Based Payments (Details Narrative) false false All Reports Book All Reports Process Flow-Through: 0002 - Statement - Consolidated Balance Sheets Process Flow-Through: Removing column 'Sep. 30, 2011' Process Flow-Through: Removing column 'Dec. 31, 2010' Process Flow-Through: 0003 - Statement - Balance Sheets (Parenthetical) Process Flow-Through: 0004 - Statement - Consolidated Statements of Operations Process Flow-Through: 0005 - Statement - Consolidated Statements of Cash Flows apnt-20120930.xml apnt-20120930.xsd apnt-20120930_cal.xml apnt-20120930_def.xml apnt-20120930_lab.xml apnt-20120930_pre.xml true true